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Shuying Wang MD, PhD 
 
University of Pittsburgh, 2006 
 
 
Decreased pain sensitivity during aging is common in humans and animals and is thought to 
reflect changes in anatomical, functional and cellular properties of the peripheral nervous system 
(PNS). We hypothesized that a reduction in neurotrophic growth factor and ion channel 
expression led to some of these age-associated changes in the PNS. To test this, a detailed 
comparative study was made of 6~8 week-, 16 month- and 2 year-old Blk6 male mice obtained 
from the NIA mouse colony. Behavioral assays showed aged mice had decreased sensitivity to 
noxious heat and impaired inflammation-induced thermal hyperalgesia. To understand the basis 
for this change we examined expression of the growth factor artemin, its receptor GFRα3 and 
TRPV1, an ion channel expressed by 95~99% of GFRα3-positive sensory neurons. TRPV1 is of 
significance since it is required for transmission of thermal hyperalgesia following tissue 
inflammation. Assays showed a reduction in TRPV1 mRNA and protein in the PNS of aged mice 
that correlated with a decrease in expression of the artemin receptor GFRα3. CFA-induced 
inflammation also increased artemin expression in the skin but decreased expression of GFRα3 
mRNA in the dorsal root ganglia (DRG) of both young and old mice. The decrease in GFRα3 
was greater in aged mice, suggesting GFRα3 signaling following CFA is also reduced and that 
the response properties of GFRα3-positive sensory neurons that express TRPV1 are diminished. 
Calcium imaging of isolated primary neurons grown with NGF was therefore used to test the in 
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vitro effects of artemin on TRPV1 activation in young and old neurons. Artemin potentiated 
TRPV1 activation by capsaicin in young and old neurons, but the amplitude of capsaicin 
responses in young neurons was decreased with long-term exposure to artemin. In studies using 
microarrays and RT-PCR, inflammation-associated genes such as interleukin 6 (IL-6) were 
found elevated in sensory ganglia of aged mice. This ongoing inflammatory state may increase 
the inflammatory tone of the system and contribute to changes in response properties and 
sensitivity of sensory neurons in the aging PNS. Thus, the reduced sensitivity to inflammatory 
pain in aged animals reflects a combination of changes in anatomical, physiologic and immune 
response properties.  
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I. OVERVIEW 
PAIN SIGNALING IN THE PERIPHERAL NOCICEPTIVE SYSTEM 
 
 
 
Pain is “an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage”, according to the International Association 
for the Study of Pain (IASP). Under normal conditions the experience of pain has an important 
protective role. In pathological conditions, the sensation of pain also has a protective response 
and functions to prevent further damage to the already injured tissue. However some 
pathological conditions, such as chronic joint inflammation or nerve injury, result in persistent 
and recurrent pain that can severely affect daily activities if left untreated. Persistent pain is more 
common in older people who are at a much higher risk for such pain-related morbidity. Although 
the relative risk and the nature of pain in elderly people is influenced by age-related painful 
diseases, co-morbid illness, and psychological changes associated with aging, accumulating 
evidence suggests that pain severity is also influenced by age-related changes in the structure and 
functional properties of the peripheral nociceptive system (PNS). To identify how changes in the 
PNS might relate to pain transmission and sensitivity with aging, we compared the cutaneous 
sensory system of young and old mice at the cellular and molecular level. The overall goal was 
to determine if age-related changes occurred in neurotrophic growth factor expression, ion 
channel expression or response properties of sensory neurons. 
 
       As a sensory organ, skin contains a dense network of highly specialized primary afferent 
nerve fibers whose cell bodies are found in the dorsal root ganglia (DRG) and trigeminal ganglia 
(TG) (Iggo and Andres, 1982). The terminals of the afferent nerve fibers form receptors that 
detect and transmit thermal, mechanical and chemical information to the central nervous system 
(CNS). Generally speaking, spinal afferent fibers from DRG neurons enter and form synapses 
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with neurons in the dorsal horn of the spinal cord, and their axons cross to the contralateral side 
and ascend to synapse on neurons in the thalamus. Thalamic neurons send fibers to the cortex 
where conscious sensation occurs (McHugh and McHugh, 2000). The first physiological step of 
complex pain processing, i.e., nociception, involves the transmission of a noxious signal by a 
subset of primary sensory neurons called nociceptors (Dubner and Bennett, 1983; Besson and 
Chaouch, 1987; Millan, 1999). Nociceptors are selectively activated by diverse noxious stimuli, 
and anatomically and functionally distinct from non-nociceptive neurons that detect innocuous 
stimuli (Caterina and Julius, 1999). Nociceptors set specific response thresholds to distinguish 
between noxious and innocuous events and reset these thresholds following injury to sensitize 
the system and prevent further injury (Julius and McCleskey, 2006).  
 
 
 
1.1 FUNCTIONAL PROPERTIES OF NOCICEPTORS 
 
Cutaneous nociceptors can be divided into two main groups based on anatomical and functional 
properties: unmyelinated C-fiber nociceptors with slower conduction velocity and myelinated A-
fiber nociceptors with faster conduction velocity (Dubner and Bennett, 1983; Djouhri and 
Lawson, 2004). There are two types of A-fiber nociceptors: type I and type II (Treede et al., 
1998). Type I fibers are present in both hairy and glabrous skin while type II are only in hairy 
skin. When a noxious stimulus is applied to the skin, activated cutaneous nociceptors generate 
and transmit an electrical signal (action potential, AP) along A-fibers and/or C-fibers to the 
dorsal horn of the spinal cord, and elicit fast sharp pain and/or slow dull pain (Julius and 
Basbaum, 2001). According to their responses to different modalities of noxious stimulation, 
nociceptors can be further classified into thermal, mechanical and chemical nociceptors. Most 
are polymodal nociceptors that respond to thermal, mechanical and chemical stimuli, whereas 
other nociceptors are activated only by a subset of these modalities (Caterina and Julius, 1999).  
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1.1.1 Thermal nociception 
 
Responses of nociceptors to heat stimuli have been studied in detail and a wide range of heat 
thresholds from 38°C to 53°C has been reported (Spray, 1986). Thermal modeling studies have 
shown that the heat threshold of nociceptors depends on the temperature at the depth of the 
receptors. The transduction of heat stimuli (conversion of heat energy to action potentials) occurs 
at different skin depths for different nociceptors and the supra-threshold responses of nociceptors 
vary directly with the rate of temperature increase (Tillman et al., 1995b, 1995a). When the rate 
of temperature increases very slowly or when stimulus duration is very long, the heat threshold 
of most C-fiber nociceptors and type II A-fiber nociceptors is between 39°C and 41°C (Tillman 
et al., 1995a), and type I A-fiber nociceptors is between  40~50°C (Treede et al., 1998; Meyer et 
al., 2006). Further studies have found that human sensation of pain to stimuli over the range of 
41~49°C correlates very well with the activity of C-fiber nociceptors (Meyer et al., 2006) and the 
thermal threshold of type II A-fiber nociceptors in hairy skin is near the threshold temperature 
for initiation of pain sensation (Beitel et al., 1977; Treede et al., 1998). These observations 
indicate a role of nociceptors in heat-induced pain sensation.  
 
1.1.2 Mechanical nociception 
 
Mechanical responses of nociceptors depend on the features of a mechanical stimulus and the 
type of nociceptor activated. Peak response occurs at the onset of the stimulus followed by slow 
adaptation to stimuli. The response of A-fiber nociceptors is greater than C-fiber nociceptors 
(Slugg et al., 2000). In general the activity of nociceptors increases with pressure and force 
except that the response of C-fiber nociceptors saturates at higher force level (Slugg et al., 2000). 
A-fiber nociceptors are thought to be responsible for transmission of sharp pain induced by 
punctate mechanical stimuli since the reaction time to perceive sharp pain is short and the 
stimulus-response function of A-fiber nociceptors is comparable with the pain ratings of human 
subjects (Magerl et al., 2001). When long-duration mechanical stimuli are applied, the pain 
increases throughout the stimulus. Certain C-fiber nociceptors that are normally insensitive to 
mechanical stimuli develop a response to prolonged mechanical stimulation, and are thought to 
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signal pain associated with tonic pressure since selective block of A-fiber nociceptors rarely 
affects the tonic pain (Andrew and Greenspan, 1999; Schmidt et al., 2000).  
 
1.1.3 Chemical nociception 
 
 A variety of chemical agents, including endogenous inflammatory mediators (e.g. acid) and 
exogenous agents (e.g. capsaicin and formalin) can activate nociceptors and produce pain 
(Reichling and Levine, 1999). Intradermal injection of capsaicin induces a long-lasting vigorous 
response in certain A- and C-fiber nociceptors and intense pain that lasts for several minutes, 
suggesting these fibers are responsible for capsaicin-induced pain (Schmelz et al., 2000; 
Ringkamp et al., 2001). A channel protein expressed in nociceptors, TRPV1, has been found to 
mediate the noxious effects of capsaicin (Caterina et al., 1997). Heat and protons can also 
activate TRPV1, indicating that neurons expressing TRPV1 may be polymodal nociceptors.  It 
should be mentioned that most chemical agents probably cause tissue injury and hence induce 
pain, which is particularly true for inflammation-induced pain. 
 
       A common feature found in nociceptors that respond to thermal, mechanical and/or chemical 
(capsaicin) stimuli, is time-dependent desensitization by repeated stimuli, which is a reduction of 
the response to the second of two identical stimuli compared with the response to the first one, 
and in turn results in a reduction in pain intensity following repeated stimuli (Slugg et al., 2000; 
Witting et al., 2000; Peng et al., 2003). The mechanism for capsaicin-induced desensitization has 
been intensively studied. In addition, nociceptors not only encode the intensity and modality but 
also encode spatial localization of noxious cutaneous stimuli, and actual pain thresholds are 
higher in vivo than the thresholds for activation of individual nociceptors, indicating 
involvement of central mechanisms in regulation of nociception (Millan, 1999).  
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1.2 MOLECULAR PROPERTIES OF NOCICEPTORS 
 
Over the past two decades rapid progress has been made in defining the molecular and cellular 
mechanisms of cutaneous nociception. Physiological function of nociceptors depends on distinct 
expression of receptors and ion channels that can be activated by noxious stimuli. These 
nociceptive receptors and ion channels detect specific physical or chemical stimuli and induce 
membrane depolarization. Voltage-gated ion channels are in turn activated and produce APs, and 
result in neurotransmitter release at spinal synapses. Among these receptors and ion channels, 
transient receptor potential ion channel (TRP)-related TRPVs, acid-sensing ion channels (ASICs) 
and purinergic ionotropic receptors (P2X2 and P2X3) have been well studied and recognized as 
molecular detectors of noxious thermal, mechanical or chemical stimuli (Caterina and Julius, 
1999; Julius and Basbaum, 2001). 
 
1.2.1 Molecular detectors of noxious stimuli 
 
As mentioned before some nociceptors have a lower thermal threshold than others. In vitro 
studies also show that about 45% of DRG neurons respond to heat with a threshold of ~ 42°C 
while 5~10% respond with a higher threshold of ~ 51°C (Nagy and Rang, 1999). The difference 
of nociceptors in thermal threshold is determined by specific expression of heat-sensitive ion 
channels, especially TRPVs. TRPV1 is predominantly expressed in unmyelinated C-fiber 
nociceptors and has a thermal activation threshold of ~ 43°C, indicating involvement of TRPV1 
in thermal response of nociceptors with lower threshold (Caterina et al., 1997; Tominaga et al., 
1998; Michael and Priestley, 1999; Caterina et al., 2000). TRPV2, mainly present in myelinated 
A-fiber nociceptors, has a thermal threshold of ~ 52°C and is thought to mediate high threshold 
heat responses (Caterina et al., 1999). TRPV3 and TRPV4 have been found to respond to heat 
with thermal threshold between 31 and 39°C, but their expression and function in thermal 
nociceptors is controversial (Guler et al., 2002; Peier et al., 2002; Smith et al., 2002; Watanabe et 
al., 2002; Xu et al., 2002). TRPV4 can also be activated by changes in osmolarity suggesting that 
TRPV4 might be also involved in mechanosensation (Liedtke et al., 2000; Strotmann et al., 
2000; Suzuki et al., 2003b).  
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       Despite the fact that mechanosensitive channels such as ASIC1, ASIC2 and TRPV4 are 
present in nociceptors (Alvarez de la Rosa et al., 2002), molecular detectors of mechanical stress 
remain elusive since deletion of ASICs or TRPV4 genes only produces subtle changes in 
mechanosensation, osmoregulation or nociception (Price et al., 2000; Price et al., 2001; Suzuki et 
al., 2003a). Though some chemical agents like capsaicin can directly produce pain via activation 
of TRPV1, most noxious chemical stimuli are endogenously released following tissue injury. 
Acidosis is a common consequence of injuries associated with inflammation and ischemia. 
TRPV1 and ASICs are thought to mediate acid-induced pain since both can be activated by 
protons as well as expressed in acid-responsive nociceptors (Caterina et al., 1997; Caterina et al., 
2000; Price et al., 2000; Price et al., 2001; Alvarez de la Rosa et al., 2002). Tissue injury also 
results in ATP release from damaged cells. ATP can directly activate the purinergic ionotropic 
receptors P2X2 and P2X3, which are preferentially expressed in nociceptors, and induce the 
sensation of pain (Chen et al., 1995; Lewis et al., 1995; Cook et al., 1997; North, 2004). 
 
1.2.2 Molecular signal transducers  
 
Once the molecular detectors in nociceptors are activated by noxious stimuli, voltage-gated ion 
channels are opened by membrane depolarization and action potentials are produced and 
propagated. Action potentials of nociceptors are remarkably long in duration and relatively slow 
at firing rate (Koltzenburg et al., 1997; Djouhri et al., 1998). To date many types of voltage-
gated sodium, potassium and calcium channels have been identified in primary sensory neurons, 
but only some are specifically or preferentially expressed in nociceptors, which might be the 
molecular basis for the distinct excitability of nociceptors. Two of them are tetrodotoxin (TTX)-
resistant voltage-gated sodium channels Nav1.8 and Nav1.9 (Akopian et al., 1999; Amaya et al., 
2000; Fang et al., 2002; Djouhri et al., 2003). Slow inactivation of these two channels leads to 
long duration of APs in nociceptors (Djouhri et al., 2003). Voltage-gated calcium channels 
(VGCC), such as N-type voltage-gated calcium channel Cav2.2, also shapes the prolonged 
shoulder of APs in nociceptors (Blair and Bean, 2002). Studies have shown that Cav2.2 carries 
the bulk of calcium current in sensory neurons and the fraction is relatively higher in nociceptors 
than in others, and neurotransmission at the first synapse in the nociceptive pathway mainly 
relies on Cav2.2 (Mintz et al., 1992; Gruner and Silva, 1994; Cardenas et al., 1995; Rusin and 
 7 
Moises, 1995; Kim et al., 2001). A splicing variant of Cav2.2, e37a, has been reported to be 
preferentially expressed in capsaicin-responsive neurons (Bell et al., 2004). These findings 
indicate relative specificity of involvement of Cav2.2 in nociception. 
 
1.2.3 Molecular properties determine nociceptor function 
 
The molecular detectors of noxious stimuli plus voltage-gated ion channels for signal 
propagation determine sensitivity and activity of nociceptors. Changes in expression and/or 
function of these nociceptive channels and receptors may result in functional changes of 
nociceptors. It has been reported that increased expression or activity of Nav1.8 and Nav1.9 
results in increased sodium conductance, decreased AP threshold, and increased activation rate 
and firing rate, and in turn causes hyper-excitability of sensory neurons (Gold, 1999; Waxman et 
al., 1999). Other studies also have shown that in control DRG neurons, ATP or protons only 
induce sub-threshold membrane depolarization while in inflamed neurons with increased 
expression of ASIC3 or P2X2/3 the same pH drop or the same amount of ATP evokes supra-
threshold depolarization and triggers action potentials, indicating that up-regulation of detector 
proteins may contribute to hypersensitivity and hyper-excitability of sensory neurons (Mamet et 
al., 2002; Xu and Huang, 2002). In vivo inflammation not only causes persistent pain but also 
hyperalgesia, an increased response to a stimulus that is normally painful, and allodynia, a 
painful response due to a stimulus which does not normally provoke pain. The molecular basis 
for increased sensitivity and activity of nociceptors during inflammation is consistent with the 
molecular mechanism of nociception discussed above. In general, inflammation increases 
expression and/or function of nociceptive-related channels, thus decreasing activation thresholds 
and increasing AP production in nociceptors resulting in pain (Okuse et al., 1997; Gold, 1999; 
Waxman, 1999; Waxman et al., 1999; Voilley et al., 2001; Ji et al., 2002; Xu and Huang, 2002). 
This model is also consistent with the finding that deletion of these channels either decreases or 
slows occurrence of inflammatory pain (Barclay et al., 2002; Walker et al., 2003). During 
inflammation channel expression and/or function in nociceptors can be modulated by nerve 
growth factor (NGF). NGF binds to the TrkA receptor tyrosine kinase (RTK) receptor, and 
activates second message signaling pathways that are thought to regulate gene expression or 
modification, i.e. phosphorylation, of channel proteins (Julius and Basbaum, 2001).  
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1.3 REGULATION OF NOCICEPTOR FUNCTION 
 
Neurotrophic factors regulate the long-term survival, growth and differentiated function of 
distinct populations of sensory neurons. Multiple types of cells can produce neurotrophic factors, 
including those in target tissues such as the skin, supporting glial cells in sensory ganglia such as 
the satellite and Schwann cells and immune cells that are found in the skin and ganglia, e.g., 
macrophages (Batchelor et al., 1999). Two families of neurotrophic factors, the neurotrophin 
family, comprised of NGF, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) 
and neurotrophin-4 (NT-4), and the glial cell line-derived neurotrophic factor (GDNF) family, 
have been found to be required for development, maintenance and function of sensory neurons. 
The action of neurotrophic factors depends on their binding to transmembrane receptors. NGF 
binds to the receptor p75 and the receptor tyrosine kinase TrkA (Barbacid, 1995; Chao and 
Hempstead, 1995). GDNF binds to the Ret receptor tyrosine kinase and to a glycosyl-
phosphatidyl inositol (GPI)-anchored receptor GFRα (Saarma and Sariola, 1999). Based on the 
requirement for trophic factors, nociceptors can be divided into two groups: NGF-dependent 
nociceptors, which express peptides such as calcitonin gene-related peptide (CGRP) and 
substance P (SP), and GDNF-dependent nociceptors, which are peptide poor and bind the plant 
isolectin B4 (IB4) (Snider and McMahon, 1998). In adult rodents about 40% of DRG neurons 
are NGF-dependent and 30% are GDNF-dependent (Molliver et al., 1997). Although the two 
groups of nociceptors may have distinct roles in pain sensation, neurons in each group respond to 
capsaicin and heat and in rat, many express TRPV1 (Tominaga et al., 1998; Michael and 
Priestley, 1999).  
 
1.3.1 NGF 
 
The important role of NGF in development and differentiation of nociceptors has been well 
established. NGF also regulates nociceptor function in the adult (Bennett, 2001). In vitro studies 
have shown that NGF regulates gene expression of SP and CGRP in cultured adult DRG neurons 
as well as chemical sensitivity of nociceptors to capsaicin and protons (Winter et al., 1988; 
Lindsay and Harmar, 1989; Bevan and Winter, 1995). In vivo studies have found that 
subcutaneous administration of NGF sensitizes nociceptors to thermal and chemical stimuli and 
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causes hyperalgesia (Lewin et al., 1993). Further studies indicate that local infusion of anti-TrkA 
IgG, an NGF signaling antagonist, decreases thermal and chemical sensitivity of nociceptors and 
leads to thermal hypoalgesia, suggesting TrkA is required for regulation of nociceptor function 
by NGF (McMahon et al., 1995). By binding and activating TrkA-mediated signaling pathways 
NGF regulates not only expression but also post-translational modification of receptors and ion 
channels involved in nociception such as TRPV1 and Nav1.8 (Gold et al., 1998; Kerr et al., 
2001; Bonnington and McNaughton, 2003; Zhang et al., 2005). Increased expression and specific 
phosphorylation of TRPV1 and Nav1.8 by NGF are thought to contribute to NGF-induced 
sensitization of nociceptors (Julius and Basbaum, 2001; Kerr et al., 2001; Ji et al., 2002).  
       
       It is clear now that NGF can act as an inflammatory mediator and is essential for 
inflammatory hyperalgesia (Mendell et al., 1999; Bennett, 2001). NGF has been found to 
increase in inflamed tissue, and this increase may be secondary to cytokine production, such as 
IL-1 and TNFα (Woolf et al., 1994; Safieh-Garabedian et al., 1995; Woolf et al., 1997). Anti-
NGF or anti-TrkA treatment diminishes the hyperalgesia (Woolf et al., 1994; McMahon et al., 
1995).  During inflammation nociceptors display increased thermal and mechanical sensitivity, 
which can also be prevented by anti-NGF treatment. As mentioned above, NGF can act directly 
on nociceptors by modifying channel proteins like TRPV1 to induce hyperalgesia. In addition 
NGF can also up-regulate channel protein expression, which may contribute to long-term 
hyperalgesia (Koltzenburg et al., 1999). Another possibility is that NGF causes cytokine release 
from mast cells, acts on sympathetic efferents, or activates other signaling pathways, which can 
also be involved in hyperalgesia (Bennett, 2001). 
 
1.3.2 GDNF family ligands  
 
The role of GDNF and GDNF family ligands (GFLs) in functional regulation of nociceptors in 
the adult is less understood and more controversial. The GDNF growth factor family consists of 
GDNF, neurturin (NTN), artemin (ART) and persephin (PSP), which preferentially bind to 
GFRα1, GFRα2, GFRα3 and GFRα4, respectively. The GFRs in conjunction with the Ret form 
a receptor complex (Saarma and Sariola, 1999). GDNF, NTN and ART support the survival and 
differentiation of subpopulations of cutaneous sensory neurons in vitro (Baudet et al., 2000). 
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Disruption of GDNF results in a 23% decrease of total neurons in DRG and selective loss of 
GFRα1-expressing neurons in TG at P0 (Moore et al., 1996). However, disruption of GFRα1 has 
no effect on the survival of sensory neurons in either DRG or TG (Cacalano et al., 1998). 
Deletion of NTN causes selective loss of GFRα2-expressing neurons in TG and knockout of 
GFRα2 decreases peripheral innervation without affecting the number of DRG neurons 
(Heuckeroth et al., 1999; Rossi et al., 1999; Stucky et al., 2002; Lindfors et al., 2006). No 
deficiency has been reported in sensory ganglia of ART or GFRα3-knockout mice though 
GFRα3 is predominantly expressed in peptidergic nociceptive sensory neurons (Nishino et al., 
1999; Orozco et al., 2001; Honma et al., 2002). The lack of sensory neuron abnormalities in 
these knockout studies may be due to crosstalk among GDNF, NTN and ART signaling 
pathways (Sariola and Saarma, 2003).  
 
       The influence of GDNF on nociception may vary between rats and mice due to distinct 
difference in the expression pattern of TRPV1 in GDNF-dependent nociceptors. In rats more 
than half of GDNF-dependent nociceptors express TRPV1 whereas in mice only 2~5% are 
TRPV1-positive (Guo et al., 1999; Michael and Priestley, 1999; Zwick et al., 2002). Not 
surprising, overexpression of GDNF in mouse skin does not affect either heat thresholds of 
GDNF-dependent nociceptors or the percentage of TRPV1-expressing neurons in sensory 
ganglia since few mouse GDNF-dependent nociceptors express TRPV1. But overexpression of 
GDNF increases the percentage of GDNF-dependent, IB4-positive neurons in DRG and 
decreases mechanical thresholds of these neurons (Albers et al., 2006). Moreover, GDNF 
overexpression results in increased P2X3-positive cutaneous nerve fibers, which are highly 
expressed in GDNF-dependent nociceptors (Zwick et al., 2002).  
 
       Neurturin is also thought to support a subpopulation of neurons that have nociceptor 
properties. Approximately 50% of GFRα2–expressing neurons respond to noxious heat and 
deletion of the GFRα2 gene decreases the percentage of neurons with large heat-evoked 
response and increases the percentage of neurons with small or no heat response. Loss in neurons 
with large heat responses may contribute to a deficit in heat transduction (Stucky et al., 2002). 
These studies support a role for GDNF family members in nociception. However, neither 
overexpression nor deletion of GDNF/GFRα changes behavioral responses to noxious heat and 
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mechanical stimulation (Zwick et al., 2002; Lindfors et al., 2006), suggesting that in vivo, other 
mechanisms must be involved in nociception. 
 
       Following inflammation in the rat, anti-GDNF IgG treatments down-regulate TRPV1 
expression in nociceptors and reduce thermal hyperalgesia (Fang et al., 2003; Amaya et al., 
2004). Deletion of GFRα2 in mice also reduces inflammatory pain (Lindfors et al., 2006). 
Recent studies have shown GDNF, NTN and ART can potentiate TRPV1 function as well as 
induce capsaicin responses in a subset of DRG neurons that are normally capsaicin-insensitive, 
and injection of GDNF, NTN or ART can all produce acute thermal hyperalgesia in mice (Malin 
et al., 2006). These studies suggest that GDNF family growth factors can modulate nociceptor 
responses. Indeed, TRPV1 is expressed in 99% of GFRα3-positive, artemin responsive neurons 
in mice. In addition, overexpression of ART in the skin of transgenic mice not only increased 
gene expression of TRPV1 in sensory ganglia but also increased the density of TRPV1-positive 
afferents in the skin (Orozco et al., 2001; Elitt et al., 2006). An increased response of DRG 
neurons to capsaicin, a decreased thermal threshold of cutaneous nociceptors and an increased 
behavioral response to thermal stimuli has also been measured in mice that chronically 
overexpress artemin (ART-OE) (Elitt et al., 2006). These findings suggest a critical role of ART 
in regulation of TRPV1-mediated nociception 
 
       GFLs have also been found to be effective in reversing some of the changes in afferent 
phenotype and hypersensitivity that accompany nerve injury. In these neuropathic pain models, 
constriction of a peripheral nerve produces a pathological condition that leads to a persistent pain 
state. Nerve constriction injury is known to increase expression of the GDNF receptor GFRα1 
and the ART receptor GFRα3 in the damaged DRG (Bennett et al., 2000). This increase is 
thought to be due to the interruption of the normal retrograde trophic signaling from the target 
that is blocked by the constricted nerve. Intrathecal injection of GDNF or subcutaneous injection 
of ART reduces injury-related expression of pain-associated sensory neuron markers and relieves 
much of the behavioral hypersensitivity associated with this injury. This relief is hypothesized to 
occur through activation of signaling pathways that act to reduce sodium channel activity in 
injured DRG neurons and through inhibition of neurotransmitter release in the dorsal horn 
(Boucher et al., 2000; Gardell et al., 2003). Thus, restoration of pre-ligation trophic signaling, 
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which is interrupted by the constriction, restores normal sensitivity and produces an analgesic 
effect. These studies provide evidence for functional down-regulation of nociceptor properties by 
GDNF family factors such as ART, whose role in pain signaling in the aging system is a major 
focus of this dissertation.    
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II. INTRODUCTION 
AGING IN THE PERIPHERAL NOCICEPTIVE SYSTEM 
 
 
 
With the population of elderly people rapidly increasing in society, studies of aging and 
associated changes in the nervous system have become more essential. Neurological diseases are 
common in the aging population and account for about 50% of the disability reported in the 
elderly (Verdu et al., 2000). Aging has been defined as a process of “accumulation of diverse 
deleterious changes in the cells and tissues with advancing age that increase the risk of disease 
and death”(Harman, 2001). Based on this definition aging affects all tissues and cells, and causes 
tissue damage, cell loss and function reduction. For the nervous system aging results in decline 
of sensory, motor and cognitive functions with time, indicating all regions, including the CNS 
and the PNS, are affected. However, cells in the nervous system are differentially affected during 
aging, and neurons in some regions are more vulnerable than others, a phenomenon called 
selective neuronal vulnerability (Mattson and Magnus, 2006).  
 
       Although the mechanisms for this selective neuronal vulnerability remain unknown, it 
suggests that aging mechanisms in different regions and/or different types of neurons may vary, 
and this may also be true in the PNS. Some studies have shown that age-related changes in the 
structure and function of the peripheral sensory system affect pain sensation. However, the effect 
of age on pain remains elusive and controversial. Moreover, the mechanisms that underlie aging 
in the PNS are much less understood since most aging studies focus on the CNS. To understand 
the molecular mechanisms underlying aging in the PNS, this dissertation examined age-related 
changes at the molecular and cellular level using a mouse model system. Results indicate that 
changes in artemin/GFRα3 expression and the baseline level of inflammatory protein expression 
may contribute to age-related deficits in the peripheral nociceptive system.  
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2.1 AGE-RELATED CHANGES IN THE PERIPHERAL SENSORY SYSTEM 
 
2.1.1 Behavioral changes  
 
Many studies have been done on cutaneous sensitivity for noxious thermal, mechanical and 
electrical stimuli with age in normal human and animal models. Although some have reported 
either no age-related differences in pain sensitivity or decreased pain thresholds and increased 
sensitivity with age (Kenshalo, 1986; Heft et al., 1996; Jourdan et al., 2000; Iwata et al., 2002; 
Kitagawa et al., 2005), most studies have shown that older subjects are less sensitive to noxious 
stimuli than younger subjects (Gibson and Farrell, 2004). Studies also have investigated the 
effects of age on pain sensation under pathological conditions such as inflammation and nerve 
injury (Gagliese and Melzack, 2000). In some studies, aged animals had greater thermal 
hyperalgesia and/or mechanical allodynia compared to younger ones (Crisp et al., 2003; Zhang et 
al., 2004) while other studies showed similar or decreased responses to tissue injury in aged 
animals compared with young animals (Kitagawa et al., 2005). The lack of consensus in the 
effect of aging on pain sensitivity may be due to methodological differences (Helme et al., 2004), 
including modality, duration and sites of stimulation, models of inflammation and nerve injury, 
and the time points of behavioral tests. However, clinical studies indicate that pain is more 
frequently absent in older patients with myocardial infarction, pneumothorax, and peptic ulcer 
diseases (Gibson and Helme, 2001; Moore and Clinch, 2004). Nonetheless the weight of all 
evidence supports the conclusion that pain thresholds increase and sensitivity to noxious stimuli 
decreases with age. Pain is a key pointer to disease diagnosis in the clinic, and decrease or even 
absence of pain in some diseases may have critical implications. Though multiple interacting 
neurobiological and behavioral factors contribute to the effects of aging on pain sensitivity, the 
age-related functional deficits in pain sensation may be a consequence of age-induced 
degeneration in the peripheral nociceptive system, since both human and animal studies have 
reported that the peripheral sensory system undergoes age-related degenerative changes in both 
structure and function.  
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2.1.2 Anatomical and structural changes  
 
Age-related anatomical and structural changes in the PNS include loss of neurons and axons. 
One study found about 34% loss of total lumbar DRG neurons and 57% loss of DRG neurons 
innervating the knee joints in 24-month old mice (Salo and Tatton, 1993). However, most studies 
demonstrated that there was no decrease or only a small non-significant decrease (~12%) of total 
primary sensory neurons in DRG of 22~30-month old rats (La Forte et al., 1991; Bergman and 
Ulfhake, 1998; Mohammed and Santer, 2001). Thus, age-related sensory deficits are not simply 
of a result of neuronal death. Morphologic studies of peripheral nerves show a reduction in the 
number and density of myelinated as well as unmyelinated fibers of several animal species with 
aging (Bergman and Ulfhake, 2002; Besne et al., 2002; Ulfhak et al., 2002; Vilches et al., 2002). 
In human, both myelinated and unmyelinated fibers have been reported to decrease, with loss of 
unmyelinated fibers greater (~50%) compared to myelinated afferents (~35%) in very old age 
(65-75 years) (Verdu et al., 2000). This decrease appears to be site specific, and the degree of 
loss is greatest in the distal regions of long nerves (Flanigan et al., 1998). In parallel with this 
loss of nerve fibers in peripheral nerves, a significantly lower density of epidermal nerve profiles 
has been reported in adult and aged healthy human subjects than in young humans (McArthur et 
al., 1998). A decrease of 50% of nerve profiles was also reported in plantar skin of 24-month old 
rats (Verdu et al., 2000). In contrast, only a moderate reduction of about 10~15% in the density 
of unmyelinated sensory fibers was found in the epidermis of 18-month old mice with respect to 
young mice (Verdu et al., 2000). This may be due to compensation for the loss of terminal 
innervations by sprouting and expansion of the target territory, a compensatory mechanism 
particularly effective for thin nerve fibers. Similarly, myelinated and unmyelinated input to the 
spinal cord also decreases in aged rats, and the loss of myelinated fibers is greater than 
unmyelinated (Bergman and Ulfhake, 2002).  
 
2.1.3 Electrophysiological changes 
 
Physiological changes have been reported in peripheral sensory nerves of aged human subjects. 
Electrophysiological measures show slower nerve conduction velocity and smaller nerve action 
potential amplitude in older subjects compared to young individuals, and this decrease begins in 
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early adulthood and progresses in a relatively stable pattern (Flanigan et al., 1998; Verdu et al., 
2000). Although it has been shown that both C-fiber and A-fiber function decrease with age, one 
study found that selective block of A-fiber conduction while leaving C-fiber function intact 
increased heat pain threshold in young adults without effects on older subjects, suggesting a 
selective age-related impairment of myelinated nociceptive A-fiber function (Chakour et al., 
1996). Studies of calcium currents in rat DRG neurons found reduction of calcium current and an 
increase in the percentage of high-threshold calcium currents in 30-month old rats (Kostyuk et 
al., 1993). Consistent with these findings, a depolarization–induced increase in intracellular 
calcium transients in old neurons was also lower compared with cells isolated from 7-month-old 
rats (Kirischuk et al., 1992). Effects of aging on electrical membrane properties (EMP) of 
cultured mouse DRG neurons have been well studied (Scott et al., 1988). Old neurons have a 
number of significant alterations in EMP compared with young ones, including decreased 
electrical excitability and increased action potential duration. The pattern of altered EMP is 
consistent with an age-induced shift from voltage-sensitive sodium channels to less excitable 
voltage-dependent calcium channels (Scott et al., 1988). These findings strongly suggest that 
age-induced changes in neuronal sensitivity and excitability may result from altered expression 
and/or function of ion channels with aging. 
 
2.1.4 Cellular and molecular changes 
 
Few studies have investigated age-related cellular and molecular changes in the PNS. In lumbar 
and cervical DRG of aged rats there were decreased cellular levels of CGRP and substance P, 
two major neurotransmitters of primary afferent nociceptive fibers (Bergman et al., 1996). The 
rate of CGRP axonal transport also decreased with aging (Fernandez and Hodges-Savola, 1994; 
Hukkanen et al., 2002). Neurotrophic support is important for maintaining functional properties  
of the adult nervous system, and changes of neurotrophic signaling in the aged PNS have been 
reported. A decrease in mRNA and protein level of TrkA, TrkB and TrkC was observed in DRG 
of aged rats, and this decrease was more remarkable in lumbar DRG (Bergman et al., 1996; 
Bergman et al., 1999a). Consistent with these findings, axotomy results in down-regulation of 
these neurotrophin receptors and the effect of axotomy is less pronounced in aged animals than 
in young adults (Bergman et al., 1999a). One study found up-regulation of the GDNF receptor 
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GFRα1 and RET in primary sensory neurons (Bergman et al., 1999b). These observations 
indicate that alterations of neurotrophic signaling may be involved in age-related neuronal 
changes.   
 
       In summary, there are significant age-related changes in the peripheral nociceptive system, 
indicated by decreased number and conduction velocity of sensory nerve fibers, decreased 
neuronal excitability and decreased neurotransmitter production. All these changes reflect a 
reduction in function and likely contribute to decreased pain sensitivity. Although some studies 
found loss of neurotrophic support, others have not. Thus, a lack of neurotrophic signaling may 
not totally account for the age-induced decrease in function of the PNS. 
 
 
 
2.2 POSTULATED MECHANISMS OF NEURONAL AGING 
 
Multiple factors, including developmental/genetic and environmental factors, can contribute to 
age-related changes in cellular function. The aging process is postulated to represent an inherent 
complex process manifested at genetic, molecular, cellular, organ and system levels within an 
organism. In the nervous system the aging is reflected by a decrease in neuronal sensitivity to 
stimulation. To date the fundamental mechanisms of the inherent aging process are still poorly 
understood. Many mechanisms have been proposed for neuronal aging, including changes in 
oxidative stress, calcium homeostasis, inflammation, and the neuroendocrine system, although 
none has been completely successful in explaining the aging process of neurons. 
 
2.2.1 Oxidative stress – mitochondria theory 
 
Harman first proposed in the 1950s that damage to cellular macromolecules by free radicals 
produced in aerobic organisms is a major determinant of lifespan. The discovery of the 
contribution of reactive oxygen species (ROS), some of which are not free radicals, to oxidative 
damage to cellular constituents including lipids, nucleic acids and proteins, led to a modern 
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version of this tenet – the oxidative stress theory (Kregel and Zhang, 2006). The primary 
intracellular sites for ROS production in vivo are mitochondria. The mitochondria theory 
proposes that mitochondria are the critical component in control of aging. It hypothesizes that 
ROS can damage mitochondrial DNA (mtDNA) and components, leading to further increase in 
intracellular ROS levels and a decline in mitochondrial function. This causes cellular energy 
deficits and impaired normal cellular activity and compromises the ability of the cell to adapt to 
various physiological stresses (Shigenaga et al., 1994). The mitochondria theory has been 
supported by many studies of age-related changes in mitochondria in multiple organs of different 
species (Shigenaga et al., 1994; Kregel and Zhang, 2006). The most common and consistent 
findings show increased mtDNA damage with aging (Shigenaga et al., 1994; Hamilton et al., 
2001). The mitochondrial genome contains 37 genes and 13 of them encode proteins involved in 
the electron transport chain (Chan, 2006). Thus, accumulation of mtDNA defects can account for 
the age-related deficits in mitochondrial bioenergetic capacity and function. 
 
       Neurons appear particularly vulnerable to mitochondrial dysfunction (Chan, 2006). Neurons 
are enriched in unsaturated lipids, which are prone to oxidative damage. Accumulation of lipid 
damage can decrease fluidity and increase rigidity of plasma membranes, and lead to a decline in 
membrane receptor-mediated signaling and in turn a decrease in function (Shigenaga et al., 
1994). Moreover, age-related mtDNA deletions have been found in both the CNS and the PNS 
(Blanchard et al., 1993; Nickander et al., 2002). Recently two studies reported high levels of 
mtDNA deletions in aged human substantia nigra neurons, suggesting that mtDNA damage can 
selectively contribute to neuronal aging (Bender et al., 2006; Kraytsberg et al., 2006). A study of 
the PNS also showed that the levels of a particular deletion in mtDNA in DRG was about 300-
fold higher in 24month-old rats compared to young rats, and the abundance of this deletion 
strongly correlated with age-related decline in sensory function (Nagley et al., 2001). Besides 
mtDNA, oxidative stress also affects nuclear DNA in the nervous system. Some genes, such as 
calmodulin 1 and sortilin, are selectively vulnerable to oxidative damage in human neurons, and 
expression of these genes was decreased in human frontal cortex after age 40. These genes play 
central roles in synaptic plasticity and vesicular transport, and reduced expression may be 
directly involved in functional deficits of the aged brain (Lu et al., 2004).  
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2.2.2 Inflammation theory 
 
The fact that the aging process is accompanied by an increased incidence of various chronic 
diseases leads to a supplemental theory to oxidative stress – the molecular inflammation theory 
of aging, which connects biological aging with age-related pathological conditions. Inflammation 
represents a complex defense of an organism to intrinsic and extrinsic insults and stress. 
Accumulation of oxidative damage appears to be a primary causal factor in producing a state of 
chronic inflammation during aging (Lavrovsky et al., 2000; Chung et al., 2006; Sarkar and 
Fisher, 2006). At the molecular level the primary markers for chronic inflammation are high 
levels of inflammatory mediators, such as, IL-1, IL-6 and TNFα. Activation of transcriptional 
factors like NF-κB by age-related oxidative stress causes up-regulation of inflammatory gene 
expression and inflammatory molecule production, results in inflammation processes and 
inflammation-induced cellular and tissue damage, and contributes to the pathogenesis of age-
related diseases (Chung et al., 2001; Chung et al., 2006). There is substantial evidence 
supporting the link between aging and chronic inflammation in a wide range of tissues, organs, 
systems and species including humans. It has been well documented that inflammatory 
molecules are increased with advancing aging, though the level of inflammatory markers in age-
related chronic inflammation is much lower than the levels generated during acute inflammatory 
conditions (Kregel and Zhang, 2006).  
 
       Association of inflammation to neuronal aging in the CNS has been well studied. Increased 
expression of inflammatory genes with aging has been detected in various regions of the brain 
(Lee et al., 2000; Erraji-Benchekroun et al., 2005; Frank et al., 2006).  In the CNS glial cells 
including astrocytes and microglia play an important role in inflammation processes. Activated 
glial cells produce multiple inflammatory cytokines like IL-6, IL-1 and TNFα, which are 
deleterious to neurons (Krabbe et al., 2004). Epidemiological studies also have shown 
association between high levels of inflammatory cytokines such as IL-6 and poor cognitive 
functions in aged subjects (Yaffe et al., 2003). Long-term use of anti-inflammatory drugs 
decreases age-related increases in inflammatory markers and prevents cognitive decline (Casolini 
et al., 2002; Etminan et al., 2003; Yaffe et al., 2003).  Caloric restriction or diets enriched in 
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antioxidants not only reduce oxidative damage but also dramatically decrease inflammatory 
responses and reverse age-induced decline in neuronal function, supporting the roles of 
inflammation in the aging process of neurons (Lee et al., 2000; Gemma et al., 2002).  
 
2.2.3 Calcium theory  
 
Besides energy production, mitochondria also control intracellular calcium levels. Age-induced 
mitochondrial dysfunction can cause intracellular calcium dysregulation, which may be involved 
in neuronal aging. The calcium hypothesis of neuronal aging arose from awareness of the 
neurotoxic effects of elevated calcium (Schanne et al., 1979). Now it is well known that the free 
intracellular Ca2+ concentration plays a major role in neuronal signal transduction. Elevation of 
intracellular Ca2+ activates presynaptic neurotransmitter release, regulates membrane excitability, 
and modulates the activity of various second messenger systems and gene expression (Hartmann 
et al., 1996). The calcium theory postulates that age-dependent dysregulation of calcium 
homeostasis that result in changes in the free intracellular Ca2+ concentration account for the age-
related changes in neuronal functions (Biessels and Gispen, 1996). Regulation of intracellular 
calcium involves a complex and integrated set of systems including plasma membrane (calcium 
channels and transporters), intracellular calcium buffering (calcium binding proteins) and 
intracellular storage sites (mitochondria and endoplasmic reticulum ER). It is well recognized 
that multiple factors, such as increased calcium influx and impaired mitochondrial and ER 
function, contribute to age-related calcium dysregulation in neurons (Thibault et al., 1998).  
 
       The relationship between calcium influx via membrane calcium channels and neuronal 
function in aging has been well studied in the CNS. Most studies support the idea that age-
dependent alterations of calcium channels result in changes in intracellular Ca2+ concentration 
and account for the age-related changes in neuronal function like memory and learning (Griffith 
et al., 2000; Toescu and Verkhratsky, 2003, 2004; Toescu et al., 2004). The consistent and 
predominant findings in aged neurons include delayed recovery of intracellular Ca2+ and 
increased amplitude/duration of afterhyperpolarization (AHP) following stimulation (Disterhoft 
et al., 1996; Kirischuk and Verkhratsky, 1996). AHP is mediated by activation of Ca-dependent 
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K currents and has an inhibitory effect on neuronal excitability. The delayed recovery and 
increased intracellular Ca2+ at the end of stimulation extend the period of Ca-dependent K 
channels activation and result in a large and prolonged AHP, decreasing excitability of aged 
neurons. Further studies provided strong evidence that the changes in AHP with aging were due 
to increased high threshold VGCCs rather than K channels (Campbell et al., 1996; Landfield, 
1996; Thibault and Landfield, 1996). Similar changes with slow recovery of intracellular Ca2+, 
increased AHP and decreased electrical excitability also have been found in DRG with aging 
(Scott et al., 1988; Kirischuk and Verkhratsky, 1996). Interestingly, VGCC-mediated calcium 
influx is increased in aged neurons of mammals (Murchison and Griffith, 1995; Thibault and 
Landfield, 1996), and some anticonvulsants, which act on certain neuronal calcium channels, 
have been discovered to extend worm life span and retard the aging process, implicating that 
VGCC-mediated neural activity may be involved in aging (Evason et al., 2005).  
 
2.2.4 Neurotrophic theory 
 
Thus far none of the three theories discussed above can explain very well a common observation 
in the aging process of the nervous system - the selective neuronal vulnerability. In the CNS 
subcortical regions exhibit greater vulnerability to aging than cortical regions (Smith et al., 
1999). In the PNS loss of unmyelinated fibers during aging is greater than loss of myelinated 
fibers (Verdu et al., 2000). In the autonomic nervous system even relatively homogenous 
populations of neurons show diverse changes in old age (Cowen, 2002). The neurotrophic theory 
proposes that age-induced changes in neurotrophic factor signaling pathways may contribute to 
age-related selective neuronal vulnerability (Cowen, 1993; Gavazzi and Cowen, 1996).  As 
mentioned before, neurotrophic factors are essential for the development and maintenance of 
discrete population of neurons in the PNS and CNS.  Both peripheral targets and cells in the 
nervous system produce neurotrophic factors and promote neuronal survival and synaptic 
plasticity. Either decreased neurotrophic factor production or altered signal transduction may 
have a role in neuronal aging. Although this theory explains the selective neuronal aging to some 
degree, it remains controversial despite some supporting evidence.  
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       Age-related decreases in the expression of brain-derived neurotrophic factor (BDNF) in the 
hippocampus have been reported (Gooney et al., 2004; Hattiangady et al., 2005).  However, 
other studies did not find any age-related changes in gene expression of either BDNF and NGF 
or their receptors in the hippocampus (Lapchak et al., 1993; Rylett and Williams, 1994). The 
more consistent finding is the reduced responses of aged brain to neurotrophic factors (Smith, 
1996; Mattson and Magnus, 2006). For example, up-regulation of neurotrophic signaling in 
response to injury is impaired in aged animals (Scott et al., 1994; Smith and Cizza, 1996; Yurek 
and Fletcher-Turner, 2000).  Age-related changes in neurotrophic factor receptors also have been 
reported in the PNS (see section 2.1.4). Further studies showed decreased levels of neurotrophin 
including NGF and BDNF mRNAs in target tissues of aged rats, consistent with previous 
findings of age-related impairment in neurotrophic signaling, but GDNF was found strongly up-
regulated in target tissues (Ming et al., 1999b, 1999a). Moreover, in vitro studies indicated that 
responses of aged DRG neurons to NGF treatment were similar to young neurons, suggesting 
that NGF-mediated neurotrophic signaling was not damaged in aged sensory neurons (Jiang and 
Smith, 1995; Jiang et al., 1995; Hall et al., 2001). Therefore whether there is loss of neurotrophic 
support in the aged nervous system remains unclear. 
 
 
 
2.3 HYPOTHESES 
 
The postulated mechanisms for neuronal aging provide clues to understand the aging process of 
the peripheral nociceptive system. These theories (mitochondrial, calcium, neurotrophic support) 
interrelate with each other and likely have overlapping mechanisms that contribute to the aging 
process (Macdonald et al., 2000). In the PNS, prior studies have suggested that loss of 
neurotrophic support has a major role in aging of the PNS. Although we began this study with 
this hypothesis in mind, evidence from studies done in recent years indicates that neurotrophic 
factors in the adult system have roles other than ones of survival, i.e., they may also affect 
neuron responsiveness. Thus, although GDNF-family ligands (GFLs) support the survival and 
differentiation of specific subtypes of developing sensory neurons, in the adult PNS, the role of 
GFLs may change to one in which they modulate sensory neuron response properties, 
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particularly following inflammatory or neuropathic injury to the system (see section 1.3.2). As 
mentioned, increased GFRα1 has been reported in lumbar DRG neurons of naïve aged rats, 
supporting a role whereby elevated GFRα1 signaling down-regulates nociceptor function and 
decreases afferent sensitivity, in line with its putative role in reducing neuropathic pain in the 
young PNS. Similarly, the effects of ART/GFRα3 signaling on nociceptor function during aging 
might also influence the loss of behavioral sensitivity in aged mice. With this in mind, we 
investigated the role of GFLs in the aging sensory system to determine whether they may 
contribute to the reduced behavioral responses exhibited by older animals. 
 
The physiological function of nociceptors depends on their distinct expression of channel 
proteins such as TRPV1 and Nav1.8. In mouse DRG TRPV1 is mainly expressed in NGF-
dependent nociceptors and 67% of TRPV1-postive neurons also coexpress the ART receptor 
GFRα3, whose expression is restricted to the PNS (Yang et al., 2006). Thus, NGF and ART 
likely have major roles in the regulation of TRPV1 expression and function in the PNS of mice.  
Since no major loss of NGF-dependent neurotrophic expression occurs in the aged PNS and 
GDNF signaling does not affect nociceptors expressing TRPV1 in mice (Zwick et al., 2002), we 
hypothesized and tested whether altered ART/GFRα3 expression in the PNS during aging 
correlated with the level of expression and/or function of ion channels associated with 
nociception, such as TRPV1, in cutaneous nociceptors.  
 
Results to be presented in this study also indicate that age predominantly up-regulates 
inflammation and immune-related mRNAs in the trigeminal sensory ganglia, suggesting that 
inflammation has a major role in aging of primary sensory neurons. In the nervous system, 
infiltrating immune cells and glial cells produce inflammatory cytokines and contribute to 
inflammation. These cells also produce growth factors such as NGF, which is a known 
inflammatory mediator, suggesting that neurotrophic factors derived from immune or immune-
like cells in the sensory ganglia may be involved in age-related inflammatory changes. We 
therefore investigated whether expression of immune-related genes was altered in the aged 
sensory system.  
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       To test these hypotheses, we first investigated whether expression of ion channel and 
receptor proteins associated with nociception and neurotrophic signaling were modified in 
normal aged animals (Chapter IV). We then examined whether age-related modification of 
neurotrophic signaling and channels and receptors affected inflammation-induced pathological 
pain (Chapter V). These studies were followed by an investigation into whether the 
neurotrophic factors ART and NGF affected the functional properties of nociceptive channels 
such as TRPV1 in sensory neurons of aging animals (Chapter VI). Our results indicate that 
altered ART/GFRα3 signaling in the PNS leads to down-regulation of TRPV1 expression and 
function in nociceptors, which in turn leads to a reduction in thermal sensitivity and 
inflammation-induced thermal hyperalgesia. These findings suggest a critical role of 
ART/GFRα3 signaling in modulation of TRPV1-dependent thermal sensation in the aging PNS.  
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III. MATERIALS AND METHODS 
 
 
 
3.1 ANIMALS AND BEHAVIORAL TESTING 
 
3.1.1 Animals 
 
Young (6~8week), middle-aged (15~18month) and aged (2year) male and female C57BL/6NIA 
(B6) mice were obtained from the aging rodent colony supported by the National Institute on 
Aging at Harlan (Indianapolis, IN, USA). Upon arrival at the University of Pittsburgh animal 
facility, mice were group housed in microisolator caging and maintained on a 12-h light/dark 
cycle in a temperature-controlled environment (20.5 °C) with access to food and water ad 
libitum. These studies were carried out in accordance with the guidelines of the Institutional 
Animal Care and Use Committee at the University of Pittsburgh and the NIH Guide for the Care 
and Use of Laboratory Animals. 
 
3.1.2 Complete Freund's adjuvant-induced inflammation 
 
Detailed methods for this procedure have been reported previously (Zwick et al., 2003). Briefly 
an emulsion of complete Freund's adjuvant (CFA) was prepared by thoroughly mixing equal 
volumes of CFA (heat killed and dried Mycobacterium tuberculosis in paraffin oil and mannide 
monooleate (Sigma, St Louis, MO) with sterile saline. Twelve 6 week-old and twelve 16 month-
old mice lightly anesthetized with isoflurane received a subcutaneous injection of the CFA 
emulsion (~20 µl) in the plantar surface of the hind-paw. To determine the extent of edema, the 
diameter of the hind-paw was measured using a caliper square prior to injection and each day 
after behavioral testing. All mice showed substantial edema after CFA injection.  
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3.1.3 Hargreaves' test of thermal sensitivity 
 
Mice were placed in individual chambers (10.0 cm long × 10.0 cm wide × 13.0 cm high) of a 16-
chamber plexiglas container that was placed on top of a 6.0 mm thick glass surface (Model 390; 
IITC Inc., Woodland Hills, CA) maintained at 30°C and allowed to acclimate for 1–2 h before 
testing. Response latencies to noxious thermal stimulation were measured by applying a radiant 
heat stimulus (setting at 20% intensity for normal behavior test; for CFA study setting was at 
12% for young animals and 15% for old animals) to each hind-paw. Different heat settings were 
used in the CFA study to insure responses after CFA injection could be measured in an accurate 
manner, i.e., they were greater than 3 s. The heat source was activated with an electric trigger 
coupled to a timer, and the latency to stimulus response (flinching or lifting the paw) was 
recorded to the nearest 0.1 s. Mice were tested twice, and the responses for each paw were 
averaged. The left and right hind paw was tested on each mouse once a day for three consecutive 
days. CFA-injected animals were tested once a day, 3 days prior to CFA injection, then every 
other day for 1 week (days 1, 2, 3, 5, 7). After behavioral testing animals were given an overdose 
of Avertin (2-2-2 tribromoethanol in tert-amyl alcohol) anesthetic and perfused transcardially 
with 75 ml of ice-cold 0.9% saline. Hind-paw skin, nerves (tibial, sciatic or saphenous), DRG 
(either pooled from all levels or pooled from lumbar levels L3/L4/L5) and/or TG were collected 
on dry ice for RNA/protein analysis. 
 
 
3.2 GENE EXPRESSION ANALYSIS 
 
3.2.1 RNA isolation 
 
RNA was isolated by homogenizing frozen tissue in 1 ml of Trizol reagent (Invitrogen, Carlsbad, 
CA) followed by isopropanol precipitation. Pellets were washed with 70% ethanol, suspended in 
RNase-free water and in some cases run on an RNeasy column (Qiagen). The concentration was 
determined using a GeneQuant RNA/DNA calculator (Amersham Biosciences, Piscataway, NJ). 
RNA (5 µg) was treated with DNase (Invitrogen) to remove genomic DNA, and then 1 µg was 
reverse-transcribed using Superscript II reverse transcriptase (RT) (Invitrogen). 
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3.2.2 Microarray Assay 
 
Detailed methods for this procedure have been reported previously (Lee et al., 1999). Briefly ten 
micrograms of RNA were synthesized into cDNA and then in vitro transcribed into biotin-
labeled cRNA.  Twenty micrograms of cRNA were collected and brought to the University of 
Pittsburgh Macromolecular Analysis Faculty, and hybridized to Affymetrix mouse gene chips 
using protocols suggested by the manufacture. Affymetrix mouse genome U74Av2 
oligonucleotide microarrays representing 12,423 known transcripts and expressed sequences 
(ESTs) were used. Data were analyzed using dChip software (Harvard University). Fold 
differences between the mean signals were calculated as max/min with down regulation relative 
to young groups expressed as negative. Significance was set at P < 0.05 
 
3.2.3 Radioactive RT-PCR analysis 
 
RT-PCR reactions were done in the presence of 32P-dCTP and aliquots of the reaction run on 8% 
polyacrylamide gels in Tris borate EDTA buffer. Gels were dried and placed against a 
PhosphorImager screen, and the relative level of incorporated label was determined using a Bio-
Rad PhosphorImager (Hercules, CA). The cycle number was optimized for each set of primers 
by first running PCR reactions at different cycle numbers to establish the midphase of the 
reaction. Values were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
Primer sets were generated using Macvector software (Accelrys, San Diego, CA). Routine 
control reactions included PCR reactions on DNased RNA (without RT) and reactions run 
without templates to test for contamination. Primer sequences included the following (5' and 3', 
respectively): NGF, tccaatcctgttgagagtgg and caggctgtgtctatgcggat; ART, ctcagtctcctcagcccg and 
tccacggtcctccaggtg; GDNF, aaggtcaccagataaacaagcgg and tcacaggagccgctgcaatatc; and GAPDH, 
atgtgtccgtcgtggatctga and gctgttgaagtcgcaggagaca. 
 
3.2.4 Real-time PCR 
 
SYBR Green labeled PCR amplification was performed using a real-time thermal cycler 
(Applied Biosystems, Foster City, CA) controlled by a Dell Latitude laptop computer running
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Table 3.1 Primer sequences used for real-time PCR assays 
 
Gene      Forward primer (5'→3')   Reverse primer (5'→3') 
GFRα1   GCCACTCCTGGATTTGCTGATG  AAGTTGGTTTCCTTGCCCGC 
GFRα2  GGAAAGCCCATTGTATGACTGCC  TGAAGCGAGCCTGAAGATGTCC 
GFRα3   CTTGGTGACTACGAGTTGGATGTC  AGATTCATTTTCCAGGGTTTGC 
RET   ACTCGGCTCTCTGAGATAGACA  AGACCTTGGTCCAGGTCAACAA 
TrkA   AGAGTGGCCTCCGCTTTGT   CGCATTGGAGGACAGATTCA 
TRPV1  TTCCTGCAGAAGAGCAAGAAGC  CCCATTGTGCAGATTGAGCAT 
TRPV2  CCAGCCATTCCCTCATCAAAA  AAGTACCACAGCTGGCCCAGTA 
TRPV3  TGAAAGAAGGCATTGCCATTT  GAAACCAGGCATCTGACAGGAT  
TRPV4  TGGATTCCTTGTTCGACTACGG  CACAATGTCAAAGAGGATGGGC 
Nav1.8  GCCACCCAGTTCATTGCCTTTTC  TCCCCAGATTCTCCCAAGACATTC  
Nav1.9   TCTTCCTGGGCTCTTTCTACCTGC  CATCTTCTCCTTGGCTTCTGTCTCG 
Cav2.2  ATCCGCATCCTATTGTGGACC  GTCATCATCAAGGGCACTGTTTC 
Cav2.2-e37a  TACCTCACTCGGGACTCTTCCATC  CGCAATACAACGCAACAAACTG 
P2X3   TCCTACTTTGTGGGGTGGGTTTTC   TCTGTTGGCATAGCGTCCGAAG 
ASIC3  TTCGCTACTATGGGGAGTTCCAC  GCAGGGGATTGATGTTACACAAAG 
IL-6   TCAATTCCAGAAACCGCTATGA   CACCAGCATCAGTCCCAAGA 
LIF       AGAATCAACTGGCACAGCTCAATGG  ACATAGCTTTTCCACGTTGTTGGG 
ETRB   ACCCTGATGACCTGCGAAATGC  ACAGAGAGCAAACACGAGGACCAG 
Myelin  CTTCAATACCTGGACCACCTGTCAG GTCATTTGGAACTCGGCTGTTTTG 
GAPDH  ATGTGTCCGTCGTGGATCTGA  ATGCCTGCTTCACCACCTTCTT 
 
 
ABI Prism 7000 SDS software. Twenty nanograms of cDNA template were added to 50µl 
reaction mixtures provided in the SYBR Green reagent kit (Applied Biosystems). The 
amplification protocol included 2 min at 50 °C to activate the AmpErase UNG to prevent the 
reamplification of any carryover PCR products, 12 min at 95 °C to activate the Amplitaq 
polymerase, 40 cycles of 15 s at 95 °C for denaturation and 1 min at 60 °C for annealing and 
extension. After amplification, a dissociation curve was plotted against melting temperature to 
ensure amplification of a single product and to test for primer dimers. All samples were run in 
duplicate. Controls were run with water replacing the template (to further test for primer dimers). 
The CT values for each reaction were obtained and the ΔCT was calculated by subtraction of 
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control (GAPDH) CT from the experimental value. ΔΔCT = Mean ΔCT young − Mean ΔCT old 
and fold change = 2−ΔΔCT. An unpaired t-test (P ≤ 0.05) was used to determine significance of 
expression. PCR primers were generated using Primer Express software (Applied Biosystems, 
Foster City, CA) using parameters optimized by the manufacturer. 
 
 
 
3.3 PROTEIN ANALYSIS 
 
3.3.1 Western immunoblotting 
 
Isolated nerves and DRG (either pooled from all levels or pooled from lumbar levels L3/L4/L5) 
were analyzed. Tissues from young and aged animals were homogenized in lysis buffer 
containing 1% sodium dodecyl sulfate (SDS), 10 mM Tris–HCl (pH 7.4), 1 µg/ml pepstatin, 
1 µg/ml leupeptin, 1 µg/ml aprotinin, 1 mM sodium orthovanadate and 100 µg/ml 
phenylmethylsulfonyl fluoride (Sigma Biochemicals). Homogenates were spun 10 min at 
10,000 rpm at 4 °C, the supernatant recovered and protein concentration determined using a Bio-
Rad protein assay. Samples (10–20 µg of protein) were boiled 10 min in denaturing buffer 
containing β-mercaptoethanol and SDS, separated on either 7.5 or 10% polyacrylamide SDS-
page gels and transferred to Hybond-P PVDF membrane (Amersham Life Sciences) that was 
blocked for 1 h in TBS solution containing 5% powdered milk, 0.01% Tween-20, pH 7.6. 
Membranes were incubated with primary antibodies overnight at 4 °C. Antibodies used were: 
rabbit anti-TRPV1 (Oncogene Research Products; 1:500), goat anti-GFRα3 (R&D system, 
1:500), rabbit anti-β actin (Abcam, 1:16000), rat anti-tubulin (sera-lab, 1:100) and rabbit anti-
Nav1.8 (1:1000, a gift from Dr. S. Waxman, Yale University). Antibody binding was visualized 
using a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:10,000) and 
ECL plus detection (Amersham Life Sciences). Immunoreactive bands were analyzed by 
densitometry and their intensity quantified using NIH Image J software. Immunoblot band 
intensity was normalized to either tubulin or actin or protein bands from each sample visualized 
on Coomassie blue stained gels. Bands at the approximate molecular weight of the protein of 
interest were chosen for comparative measure. 
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3.3.2 Immunocytochemistry 
 
Tissues (DRG, TG, nerve and skin) were removed from young, aged and TRPV1 knockout 
animals that were perfused with saline. Samples were placed in 25% sucrose made in 0.1 M 
phosphate buffer (PB) overnight at 4 °C and then embedded in Optimal Cutting Temperature 
(OCT; Tissue Tek) compound on dry ice. Twenty-micron cryostat sections were mounted on 
Superfrost/Plus slides (Fisher), fixed in 4% paraformaldehyde for 10 min, blocked in 5% NGS, 
2% BSA and 0.25% Triton X-100 for 1 h and then incubated in primary antibody (rabbit anti-
TRPV1, 1:250, Oncogene Research; goat anti-artemin, 1:60, R&D system; goat anti-GFRα3, 
1:200, R&D system, rabbit anti-ETRB, 1:500, Abcam) overnight at room temperature. Antibody 
binding was visualized by avidin–biotin–peroxidase complex formation or using Cy2- or Cy3-
conjugated secondary antibodies (Vector Laboratories, Burlingame, CA). The percentage of 
TRPV1-positive or GFRα3-positive neurons was determined by first capturing entire, 
nonconsecutive labeled sections of the L4/L5 ganglia using a camera mounted on a microscope 
and Photoshop software. NIH Image software was then used to circle both labeled and unlabeled 
neurons to determine size and density of immunolabeled cells. 
 
 
 
3.4 CALCIUM IMAGING 
 
3.4.1 Cell culture 
 
Detailed methods for this procedure have been described in previous studies (Malin et al., 2006).  
2~3-month old (young) and 16~18-month old (middle-aged) male Blk6 mice from the NIA 
colony were used. All levels of DRG were dissected and placed in cold Ca2+/Mg2+-free HBSS. 
After consecutive incubation in 20U/ml papain solution and 4mg/ml collagenase solution for 10 
min at 37°C, DRG were triturated and dissociated in serum-containing media with fire-polished 
glass pipettes, and then plated onto laminin/poly-lysine coated glass coverslips. Dissociated cells 
on the coverslips were incubated at 37°C for 2 h to allow cells to attach to the coated surface. 
Cells were fed with growth media containing either 50ng/ml NGF (Harlan BioProducts) or 
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50ng/ml NGF plus 250ng/ml artemin (Biogen IDEC). DRG cultures were incubated for less than 
24 h in a CO2 incubator at 37°C before used in the calcium imaging experiments. 
 
3.4.2 Calcium imaging 
 
Isolated sensory neurons were loaded with 2 µM fura-2 in HBSS containing 5 mg/ml BSA for 30 
min at 37°C and then mounted on an Olympus Optical (Thornwood, NY) upright microscope 
stage with constantly flowing buffer at 5 ml/min. Perfusion rate was controlled with a gravity 
flow system (VC66; Warner Instruments, Hamden, CT), and perfusate temperature was 
maintained at 30°C using a heated stage and an in-line heating system (PH1, SHM-6, TC344B; 
Warner Instruments). Drugs were delivered with a rapid-switching local perfusion system. 
Firmly attached, refractile cells were identified as regions of interest in the software (Simple PCI, 
C-Imaging; Compix Imaging Systems, Sewickley, PA). All fields were first tested with brief 
application of 50 mM KCl, and Ca2+ transients were imaged to standardize pipette placement and 
to ensure that cells were healthy and responsive. Responses were measured as the ratio of 
absorbance at 340 nm to that obtained at 380 nm ( F340/380) [DG4 (Sutter Instruments, Novato, 
CA); Retiga 1300 (Burnaby, British Columbia, Canada)]; peak responses were >0.2 F340/380 and 
were easily distinguished from optical noise (< 0.02 F340/380).  
 
3.4.3 Protocols 
 
Application of 50mM KCl causes an increase in intracellular Ca2+ and was used to distinguish 
neurons from non-neuronal cells and to insure neuron viability. 50mM KCl was applied for 5s at 
the beginning of all experiments and only cells responsive to KCl application were analyzed. To 
test if CAP has direct effects on internal Ca2+ release, 1uM CAP was applied for 5s to cells in 
Ca2+-free HBSS (Figure 3.1A). For most experiments CAP was applied for 5s three times every 
10 min.  To test potentiation by ATP, 100uM ATP was applied for 30s at 7 min after the 2nd 
CAP application (Figure 3.1B). To test potentiation by ART, a 7-min perfusion of 100ng/ml 
ART was applied before the 2nd application of CAP (Figure 3.1C). 
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Figure 3.1 Protocols used in Ca2+ imaging experiments. A. Extracellular Ca2+-dependent CAP response: 
1uM CAP cannot induce Ca2+ transients in sensory neurons in the absence of extracellular Ca2+. B. 
TRPV1 potentiation by ATP: the second CAP response is diminished compared to the first one 
(desensitization) and the third CAP response following ATP application is increased compared to the 
second one (potentiation). C. TRPV1 potentiation by ART: the second CAP response following 7-minute 
perfusion of ART-containing buffer is increased compared to the first one.   
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  ________                                               ______________                          
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3.4.4 Data analysis 
 
Amplitudes (ΔF) of Ca2+ increases caused by stimulation of neurons with KCl or CAP were 
measured by subtracting the baseline ratio of F340/F380 from the peak F340/F380 achieved on 
exposure to KCl or CAP. Latencies to maximal response (Tmax) were measured between the time 
point of treatment and the one to reach the peak. Half-decay time (T1/2) represented the time 
interval in the declining phase between the peak and the half of peak ratio (Figure 6.2A). The 
first CAP responses were compared between young and old neurons. Tachyphylaxis was 
measured by comparing the amplitudes of the first two CAP responses. Potentiation was 
analyzed by comparing the amplitudes of CAP responses before and after ATP or ART 
application. All values were represented as mean ± SE. Student’s t test and ANOVA were used 
for most comparisons except that specific tests were indicated. 
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IV. RESULTS (1) 
EFFECT OF AGING ON NORMAL PAIN SENSATION 
 
 
 
In this chapter we investigated whether an age-related decline in afferent sensitivity was 
correlated with altered expression of membrane channel proteins. It is clear that afferent 
sensitivity is highly dependent on the expression of several classes of membrane channel 
proteins that regulate ion flow in response to a given stimulus. However, whether age-related 
changes in expression and/or function of ion channels contribute to altered neuronal sensitivity 
and excitability with aging is not known. To test whether changes occur in channel expression 
and distribution in the aging sensory system, we compared expression of receptors and channels, 
including the thermosensitive TRPV ion channels and the TTX-resistant sodium channels, in 
ganglia and nerves of young, middle-aged and old mice. These channels are involved in the 
generation and transmission of impulse trains in response to noxious stimuli. The relative 
expression level of receptor proteins particularly in GDNF family was also assayed to examine 
the relationship between trophic factor signaling and measured neuronal properties. We found 
reduced expression of TRPV1, Nav1.8 and other channels/receptors in the aging PNS, which 
correlated very well with a decrease in heat sensitivity in aged mice.  
 
 
 
4.1 DECREASED THERMAL SENSITIVITY IN AGED MICE 
 
We began our analysis of age-related changes in sensory neurons by comparing the behavioral 
response properties of young and old male and female C57Blk6 mice (Figure 4.1). Measures of 
response latency to an applied noxious thermal stimulus showed that, for both males and females  
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Figure 4.1 Thermal and mechanical sensitivity in young and old mice. A. Thermal sensitivity was 
decreased in both male and female 2-year old mice compared to 6-week old mice of the same sex. B. 
Mechanical sensitivity was decreased in 2-year old female mice but was not affected in aged male mice 
compared to young mice of the same sex.  * - P < 0.05, ** - P < 0.01.  
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(n = 11–12 animals/group), a longer latency occurred in 2-year old animals (Figure 4.1A). 
Comparison of all females (young and old) to all males (young and old) showed that as a group, 
females had a shorter latency than males, i.e., they were more sensitive to thermal stimuli 
(P < 0.05). In later CFA studies middle-aged (16-month old) male mice also showed a longer 
latency compared with 2-month old male mice (10.4 ± 1.3s vs. 6.0 ± 0.7s, P < 0.01, n = 12). To 
determine if differences in mechanical sensitivity are present in aged animals, von Frey filaments 
with varying thickness were applied to the hind-paw and the amount of force that evoked a 
response (lifting or licking) recorded. Although no significant difference was measured between 
young and old male mice, repeated tests indicated that aged female mice tended to have a higher 
mechanical threshold (Komolgorov–Smirnov test, P < 0.05, n = 5–6 per group) (Figure 4.1B).  
Thus, using the described assays, 24-month old female mice seemed less sensitive to both 
thermal and mechanical stimuli whereas aged males were only less sensitive to heat stimulation.   
 
 
 
4.2 REDUCED VOLTAGE-GATED CHANNELS IN DRG OF AGED MICE 
 
Voltage-gated sodium channels are responsible for the rising phase of the action potential (AP) 
and play a key role, with potassium channels, in determining the excitability of sensory neurons. 
The neuron-specific sodium channels Nav1.8 and Nav1.9 are predominantly expressed in 
nociceptors, many of which are heat sensitive. To determine whether Nav1.8 and Nav1.9 
expression are altered in aging sensory neurons, we first examined the abundance of the mRNA 
encoding each gene using reverse transcriptase-PCR assays. In pooled RNA from cervical, 
thoracic and lumbar ganglia, a slight reduction (18%; P < 0.05) in Nav1.9 mRNA was measured 
in DRG from 2-year old animals (n = 5 / age group) (Table 4.1). However, the level of Nav1.8 
transcript was reduced 43% in ganglia from 2-year old mice (Figure 4.2A and C). To examine 
expression on the protein level, proteins extracted from pooled and lumbar ganglia were 
analyzed using western immunoblotting with an antibody made to the rat Nav1.8 channel. A 
significant 37% decrease in Nav1.8 abundance was detected in pooled DRG (Figure 4.2B and 
C). Reduced Nav1.8 protein was also found in pooled lumbar DRG of both aged and middle-
aged mice (Figure 4.2B), though Nav1.8 mRNA did not change in old lumbar DRG (Table 4.1). 
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Gene expression of voltage-gated calcium channel Cav2.2, which is involved in 
neurotransmission in the nociceptive pathway, was also decreased 32% in lumbar DRG from 
middle-aged animals (n = 4 / group) (Table 4.1). These findings are consistent with decreased 
electro-excitability in aged DRG neurons reported in other studies (Scott et al., 1988). 
Interestingly, a 22% increase in expression of substance P, a neuropeptide involved in signaling 
processing of nociception (DeVane, 2001),  was measured in DRG from old mice (n = 5/group) 
(Table 4.1). This expression may compensate in part for the putative decrease in 
neurotransmission during aging.  
 
 
  
Table 4.1 Gene expression in DRG and skin of aged mice compared to young animals. The 
relative expression of mRNAs was measured using Reverse transcriptase-PCR assays. 
Class/function           Gene assayed         L2~5DRG          Pooled DRG            Footpad skin 
Channel  Nav1.8  n.c.  ↓43% * 
Nav1.9  n.d.  ↓18% *    
Cav2.2   ↓32%* n.d.   
Neurotransmitter Substance P  n.d.  ↑22% ** 
GFL receptor  GFRα2  ↓13% * n.c. 
   GFRα3   ↓32% * ↓29% * 
   RET   ↑35% ** n.c. 
Neurotrophic factor Artemin  n.d.  ↑122% *  n.c. 
   NGF   n.d.  ↑85% **  n.c. 
   GDNF   n.d.  n.c.   ↑55% **  
Glial cell expression ETRB   ↓53% * ↓37% **   
   Myelin   n.d.  ↓27% ** 
Inflammation  IL-6   ↑162%** n.d.   n.c.  
   LIF   n.d.  n.d.   ↓33%* 
 
n.d. - not done, n.c.- no change, * - P < 0.05, ** - P < 0.01  
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Figure 4.2 Decreased expression of Nav1.8 in DRG of old male mice. A. Abundance of Nav1.8 mRNA 
determined using 32P-dCTP spiked RT-PCR assasys was found to be decreased in pooled DRG from 2-
year old mice compared to 6-week old mice (n = 5). Actin was used as a control for the reaction and gel 
loading. B. Relative amount of Nav1.8 protein measured using western blotting was also decreased in 
pooled DRG (n = 3) and pooled lumbar 3-5 DRG (from 3 animals each age group) of aged mice. 
Coomassie stained gel of DRG samples is shown beneath blot to show sample loading. C. Relative 
intensity of Nav1.8 mRNA and protein bands in pooled DRG was measured. The mean intensity level of 
mRNA and protein was decreased in aged DRG by 43% and 37% compared to samples from young 
DRG, respectively. * - P < 0.05 
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4.3 REDUCED TRPV1 PROTEIN IN THE AGED PNS 
 
The reduced behavioral sensitivity exhibited by middle-aged and aged Blk6 mice indicated that 
aged animals are less sensitive to thermal stimuli applied to the foot. To begin to identify the 
cellular level changes that could underlie this reduction in thermal sensitivity, we analyzed the 
expression of genes in the thermosensitive TRP channel family in young and aged DRG. We 
focused on the TRPV (TRPV1, TRPV2, TRPV3 and TRPV4) channels that are known to be heat 
responsive. Expression in pooled ganglia from the L3/L4/L5 lumbar ganglia was first analyzed 
using RT-PCR. Only lumbar ganglia were analyzed in order to enrich for neurons that innervate 
the hind-foot, which is the site of behavioral testing. Both pooled and lumbar DRG samples 
showed no difference in TRP expression on the transcriptional level (data not shown). To 
determine whether an age-related reduction occurred for TRP channels on the translational level, 
we analyzed TRPV1 expression in protein extracts obtained from pooled DRG and lumbar DRG 
using western immunoblotting. Analysis of pooled DRG showed no statistically significant 
change in TRPV1 (P = 0.06), whereas in lumbar DRG, a reduction in TRPV1 in aging ganglia 
was present at 15 months of age that was further reduced in 2 yr-old ganglia (Figure 4.3A). 
These results suggest that the amount of TRPV1 protein steadily declines in aged neurons despite 
the lack of change on the RNA level. In addition, this decline may be greater in neurons that 
project to distal targets in the leg and foot. To examine TRPV1 expression on a per cell level, 
L4/L5 DRG were immunolabeled with TRPV1 antibody to determine the percentage of neurons 
that express TRPV1 in young and aged ganglia (Figure 4.3B). The percentage of TRPV1-
positive neurons in DRG from 2–3-month old mice was not different from the percent of 
TRPV1-positive neurons in 2-year old ganglia (young, 51.4 ± 5% versus old, 50.3 ± 5.8%). 
Coupled with the reduction of TRPV1 protein detected by immunoblotting, these data suggest 
that on a per cell level, the decrease in TRPV1 protein may be related to translational processing. 
 
       The reduced level of TRPV1 protein in DRG of aged mice led us to ask whether the 
terminals of these sensory neurons would also exhibit deficiency in TRPV1 level. Tibial nerves 
from young and old animals were immunolabeled using the anti-TRPV1 antibody to test this 
possibility. Immunolabeling showed an apparent reduction in the number of TRPV1 positive 
fibers in nerves from aged animals (Figure 4.4C). To verify this decrease we isolated protein 
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Figure 4.3 Expression of TRPV1 in DRG of young and aged mice. A. Relative amount of TRPV1 protein 
in pooled DRG (n = 3/group) and lumbar (L3~5) DRG of young and old animals was determined using 
western blotting. No significant decrease in TRPV1 level in pooled DRG was found. A decrease in 
lumbar DRG pooled from 3 animals (9 animals total) was detected in 15month-old (9%) and 2year-old 
animals (27%) when compared to 6 week-old mice. Coomassie stained gel of DRG samples is shown 
beneath blot to show loading. B. TRPV1 immunolabeling of L4/5 DRG of young and old mice shows 
prominent expression in smaller neurons. Lighter labeling was also found in some neurons. Both types of 
labeled cells were counted as TRPV1-positive. The percentage of TRPV1-labeled neurons was 51% ± 5% 
in young L4/5 DRG and 50% ± 6% in old DRG, and does not change with age.  Bar in B = 50µM  
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Figure 4.4 Decreased TRPV1 in peripheral nerves of aged mice. A. Western blot of TRPV1 protein in 
tibial nerves of young and old animals (n = 3/group) show TRPV1 reduction in aged samples. B. Plot of 
band intensity measured from immunoblot shown in A. C. Immunolabeling of sections of tibial nerve 
from young and aged animals. A reduction of TRPV1 fibers appears in nerve from old animals. D. 
Western blot also shows decreased TRPV1 in aged cutaneous saphenous nerves. Each lane represents a 
sample pooled from 3 young and 3 aged mice. E. TRPV1 fibers in epidermis (left arrow) and nerve 
bundles in deep dermis (right arrow) of plantar skin. F. TRPV1 fibers in dermal nerve bundles were 
compared in young and aged mice. Note reduction in TRPV1 labeling in aged mice and no labeling in 
nerves of TRPV1 knockout mice. 
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from the tibial and saphenous nerve. Whereas the tibial nerve primarily contains nerve fibers 
innervating muscle and skin, the saphenous nerve is a purely cutaneous nerve that innervates the 
skin of the leg and foot. A significant reduction in the level of TRPV1 protein in tibial (52%, 
P < 0.05) and saphenous nerve samples (25%,) was measured (Figure 4.4A, B and D). To 
determine if TRPV1 was reduced in sensory afferents in the skin of aged animals, we compared 
the density of TRPV1-positive fibers in the footpad of young and aged animals. Although the 
anatomical variation in the footpad hindered the quantitative measure of TRPV1-positive fibers, 
a general decrease in TRPV1-positive fibers was apparent when comparing the overall number 
of TRPV1-positive fibers coursing through the nerve bundles in the deep dermal tissue of the 
foot (Figure 4.4E and F). TRPV1 afferents appeared fewer in the aged animals, which is 
consistent with the reduction in TRPV1-labeled fibers in the tibial and saphenous nerves. 
 
 
 
4.4 REDUCED GFRα3 RECEPTOR IN AGED SENSORY GANGLIA 
 
Accumulating evidence suggests that the maintenance and sensitivity of sensory neurons is 
modulated by the level of trophic support provided by cells in peripheral and ganglionic tissues. 
This support appears to decline in aging systems, as evidenced by the reduction in mRNAs 
encoding the Trk neurotrophin receptors in sensory neurons of the aging rat (Bergman et al., 
1996; Bergman et al., 1999a). A decline in growth factor support and signaling may impede 
synthesis and transport of neuron specific proteins (e.g., TRPV1 channels) and thereby reduce 
neuronal sensitivity, leading to higher response thresholds to thermal stimuli. With this 
possibility in mind, we examined expression of receptors for artemin, a neurotrophic factor that 
supports a nociceptor neuron population that expresses high levels of TRPV1. We examined the 
relative expression of the artemin specific GPI-linked binding component GFRα3 and its 
associated signaling component, the tyrosine kinase receptor RET in lumbar DRG using RT-
PCR and immunoblot assays (Table 4.1). Relative to young animals, GFRα3 mRNA was 
reduced 32% in lumbar DRG in 15-month old animals. Protein level expression of GFRα3 was 
also reduced as shown by immunoblot assay of lumbar DRG pooled from three animals of each
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Figure 4.5 Expression of GFRα3 receptor in lumbar DRG of young and old mice. A. Western blot of 
protein extracted from lumbar DRG indicates reduction of GRFα3 in aging animals. Each lane represents 
protein pooled from three animals at each age analyzed. B. Plot of band intensity measured from 
immunoblot shown in A.  The amount of GFRα3 decreased 24% and 23% in 15-month and 2-year age 
group, respectively.  C. GFRα3 immunolabeling of L4/5 DRG of young and old mice shows prominent 
expression in smaller neurons. Lighter labeling was also found in some neurons. Both types of labeled 
cells were counted as GFRα3-positive. The percentage of GFRα3-labeled neurons was 31% ± 2.6% in 
young L4/5 DRG and 28% ± 0.7% in old DRG, and does not change with age.  Bar in B = 50µM   
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age group (total of nine animals) (Figure 4.5A and B). A 24% reduction was measured in the 
level of GFRα3 protein in the lumbar ganglia of 15-month old animals relative to 6-week old 
animals. Thus both transcriptional and translational down-regulation of GFRα3 occurred in aged 
ganglia. However, the percentage of GFRα3-positive neurons in lumbar DRG from 2–3-month 
old mice was not different from the percentage in 16-month old ganglia (young, 31% ± 2.6%; 
old, 28% ± 0.7%) (Figure 4.5C), indicating that there was no loss in GFRα3-positive neurons in 
DRG of aged mice. We also examined the relative expression level of other GDNF-ligand 
binding molecules. Measure of GFRα1, which binds GDNF, showed no significant change in 
expression in aging DRG (contrary to the increase found in aging rats), whereas GFRα2, which 
binds neurturin, was slightly decreased (13%, P < 0.05). Interestingly, the RET tyrosine kinase 
receptor, which is the signaling component for all GDNF-family ligands, was increased 35% in 
the aged DRG (P < 0.01) (Table 4.1). 
 
 
 
4.5 AGE-REGULATED GENES IN SENSORY GANGLIA AND SKIN 
 
To determine whether the age-induced decrease in TRPV1 and GFRα3 expression in the 
cutaneous sensory system correlates with a change in neurotrophic factor expression, we 
measured mRNAs encoding NGF, GDNF and ART in DRG and hind-paw skin using RT-PCR. 
In aged skin an increase in GDNF was detected but no change was found in ART or NGF 
mRNAs. In DRG of aging animals, expression of the ART and NGF growth factors increased 
while the level of GDNF mRNA was unchanged (Table 4.1). The NGF receptor TrkA and 
GDNF receptor GFRα1 were also unchanged (data not shown), although RET increased in the 
aged DRG. In contrast, expression of the GFRα3 receptor decreased in aged ganglia. To identify 
the source of the increased level of ART expression in the aging ganglia, we carried out 
immunolabeling of artemin in young and old TG and lumbar DRG. This analysis showed ART 
reactivity localized primarily in small support cells that encircle the sensory neurons (Figure 
4.6A). Interestingly, ganglia of old mice exhibited a significantly greater level of artemin 
reactivity in these peri-neuronal support cells compared to ganglia from young animals (Figure 
4.6B and C). This increase correlates with the increase in ART mRNA measured using RT-PCR. 
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Figure 4.6 Expression of ART in sensory ganglia of young and old mice. A. Immunolabeling of ART in 
sensory ganglia shows that ART reactivity localizes primarily in small support cells (arrow) that encircle 
the sensory neurons (asterisk). B. In TG, old mice exhibite a significantly greater level of artemin 
reactivity in these peri-neuronal support cells compared to cells from young animals. C. Similar to TG, 
the level of ART immunoreactivity in these peri-neuronal support cells of lumbar DRG of old mice is also 
significantly higher compared to ganglia of young mice.   
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       We further analyze gene expression in trigeminal sensory ganglia of 6wk-old and 2yr-old 
mice (n = 3/group) using Affymetrix microarrays. For this analysis, a regulated gene was defined 
as one with a fold difference significantly greater than 1.5 (P < 0.05) (Costigan et al., 2002).  
Seven of the total 16 changed genes in female (Table 4.2) and 6 of 21 regulated genes in male 
(Table 4.3) were immune/inflammation related, e.g., complement and lysozyme. Although the 
source of the elevated immune/inflammation-related transcripts in the aged ganglia is not yet 
defined, they may be from infiltrating macrophages and leukocytes. These cells are known to 
enter sensory ganglia, particularly following viral infection (Kodukula et al., 1999). Satellite 
cells and Schwann cells are also a possible source since they have been reported to synthesize 
inflammatory cytokines as well (Watkins and Maier, 2002). Microarray analysis also showed 
decreased expression of other genes such as endothelin receptor B (ETRB) and myelin (Table 
4.2), which are expressed in satellite support cells and Schwann cells, respectively. The decrease 
in these transcripts was also found in the DRG (Table 4.1). The reduced expression of ETRB in 
support cells coupled with the increased expression of ART in these cells suggest that the 
functional properties of satellite cells changes in the aging system. 
 
 
 
4.6 CONCLUSIONS  
 
These studies examined changes in genes and/or proteins associated with nociception, 
neurotrophic support and inflammation in trigeminal ganglia and DRG of young and aged mice. 
We found a decrease in expression of channel proteins (TRPV1, Nav1.8 and Nav1.9, and 
Cav2.2) involved in detection and transmission of noxious stimuli in the aging PNS. This 
decrease correlated with impaired sensation of noxious heat measured in aged animals. 
Reduction of these channels in the PNS may be a consequence of decreased signaling through 
GFRα3 pathways, which may result from aging-induced degeneration of primary sensory 
neurons and/or neuronal-support cells. Increased expression of immune/inflammation genes in 
the PNS with aging suggests that age-related immune/inflammation responses may also have a 
critical role in age-induced neuronal degeneration in the peripheral nociceptive system. 
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Table 4.2 Regulated genes in trigeminal ganglia of 2 yr-old female mice compared with 6 wk-
old female mice using microarray assay. 
 
Class/function             Gene                 Accession#     Fold change 
Immune/   S100 calcium binding protein A8   M83218  3.6↑ 
Inflammation  Lysozyme      M21050  2.7↑ 
   S100 calcium binding protein A11  U41341  1.6↑ 
S100 calcium binding protein A9   M83219  1.6↑ 
   Complement component 4    X06454  1.6↑ 
Macrophage expressed gene 1  L20315  1.5↑ 
Lymphocyte antigen 6 complex  U47737  1.5↓ 
 
ECM protein/   Procollagen, type I, alpha 1   U03419   1.9↓ 
Cytoskeleton  Procollagen, type III, alpha 1   X52046  1.8↓  
 
Hormone/   Prolactin      X04418  8.5↑ 
Neuropeptide  Glycoprotein hormones    AV173687  3.1↑ 
Tachykinin 1      D17584  1.5↑ 
 
Enzyme  UDP-glucuronosyltransferase 8   U48896  2.3↓ 
ATPase aminophospholipid transporter U75321  1.8↓ 
    
Glial expression Proteolipid protein (myelin)    M16472  2.4↓ 
    
Unknown  H19 fetal liver mRNA   X58196  1.7↓ 
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Table 4.3 Regulated genes in trigeminal ganglia of 2 yr-old male mice compared with 6 wk-old 
male mice using microarray assay. 
 
Class/function             Gene                 Accession#     Fold change 
Immune/   Immunoglobulin kappa chain   M18237  3.4↑           
Inflammation  Lysozyme      M21050  2.1↑ 
   P lysozyme structural    X51547  2.0↑ 
   S100 calcium binding protein A8   M83218  2.0↑ 
   Mus castaneus IgK chain gene  M80423  1.8↑ 
   Complement component 4    X06454  1.5↑ 
 
ECM protein/   Follistatin-related protein (TSC-36)   M91380  1.7↑ 
Cytoskeleton   Scgn10 like-protein    AF069708  1.5↑ 
   Reelin      U24703  1.5↑ 
   Microtubule-associated protein 4  M72414  1.5↑ 
   Procollagen, type I, alpha 1   U03419   2.5↓ 
   Procollagen, type I, alpha 2   X58251  2.1↓  
   Procollagen, type III, alpha 1   X52046  2.1↓ 
   Procollagen, type IV, alpha 1   M15832  2.0↓  
   Procollagen, type XV    AF011450  1.7↓ 
 
Protein/  Proteasome (prosome, macropain) subunit AB003304  1.6↑ 
Lipid turnover  Apolipoprotein D    X82648  1.6↑ 
 
Glial expression Proteolipid protein (myelin)    M16472  1.6↓ 
   Endothelin receptor type B    U32329  2.1↓ 
 
Unknown  H19 fetal liver mRNA   X58196  1.7↓ 
   Integral membrane protein 2A  L38971  1.6↓ 
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V. RESULTS (2) 
EFFECT OF AGING ON INFLAMMATION-INDUCED HYPERALGESIA 
 
 
 
5.1 INTRODUCTION 
 
Injury, infection or irritation of the skin, muscle or internal organs is often accompanied by 
inflammation related pain. An inflammatory state is recognized on the histological level by a 
large infiltration of the damaged tissue with various types of inflammatory cells that include 
neutrophils, macrophages and mast cells. These cells and cells at the site of injury release 
substances such as ATP, NGF and cytokines that can excite nociceptor neurons through 
activation of receptors on nerve terminals and in so doing, cause pain. Chronic, long-term release 
of inflammatory mediators can lead to changes in nociceptive pathways that may underlie 
persistent pain states. These changes may include abnormal expression of channel proteins and 
neuropeptide receptors on primary and secondary afferents. The most consistent reports about 
age differences in pain are the experience of acute pain related to specific pathological insults or 
infectious process. Clinical studies indicate that pain is more frequently absent in older patients 
with myocardial infarction, pneumothorax, and peptic ulcer diseases (Gibson and Helme, 2001; 
Moore and Clinch, 2004). Animal studies also have shown that inflammatory or neuropathic pain 
is modulated with aging in rat (Gagliese and Melzack, 1999, 2000). However, whether aging 
increases or decreases inflammatory pain responses is still controversial. Also undetermined is 
whether age-related differences in ion channel proteins contribute to different behavioral 
responses with age (Zhang et al., 2004; Kitagawa et al., 2005).        
 
       In this chapter we investigated whether aging modulated the response to noxious stimuli 
following CFA-induced peripheral inflammation, and whether this modulation was associated 
with age-related changes in channel proteins and neurotrophic signaling. Our results indicate that 
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inflammation-induced hyperalgesia was decreased in aged animals. This finding is consistent 
with a decrease in gene expression of the pain-related channels Nav1.8, TRPV1 and ASIC3 in 
aged animals during inflammation. In these studies we also measured the relative level of 
inflammation-associated transcripts. Age-related changes in gene expression of inflammatory 
cytokines IL-6 and leukemia inhibitory factor (LIF) correlated with changes in ART-GFRα3 
expression. We postulate that under conditions of inflammation, expression of ART-GFRα3 
regulates TRPV1 channel expression. These findings support the role of ART-GFRα3 signaling 
in age-induced functional deficits of the PNS.  
 
 
 
5.2 AGED MICE EXHIBIT REDUCED THERMAL HYPERALGESIA 
 
Prior to induction of inflammatory pain, mice were exposed to several days of pre-testing to 
determine an accurate baseline for each age group. Similar to our prior assay of behavior 
sensitivity, we found old mice less sensitive to noxious heat compared to young mice.  Therefore 
a higher intensity of thermal stimulation (15%) was applied to aged animals compared with 
young animals (12%) to get an optimal baseline (young, 7.0 ± 0.6s; old, 7.8 ± 0.5s). At day 0, 12 
young (8-week) and 12 old (16-month) mice were injected in the hind-paw with ~20ul of CFA. 
An expected peripheral edema in the hind-paw occurred following CFA injection that lasted for 
the 7 days of testing. In previous studies (Malin et al, unpublished) using young Blk6 male mice 
from Jackson Labs, CFA injection into the footpad caused thermal hyperalgesia that began 
within 1 day following injection and lasted for at least 3 days (Figure 5.1A). However, using 
young Blk6 mice from the NIA colony obtained from Harlan, thermal hyperalgesia was detected 
only on day 1 (4.3 ± 0.5s, P = 0.002) with full recovery by day 2 (Figure 5.1B). Also of interest 
was that no significant behavioral change was found in the aged mice from Harlan, although 
there was a trend toward a decrease in withdrawal latency on the first two days following CFA 
injection (day 1, 5.7 ± 1.1s; day 2, 6.1 ± 0.8s; P = 0.086) (Figure 5.1B). The short duration of 
hyperalgesia between the young (and lack of change in old mice) was surprising given that both 
sets of mice are of the Blk6 strain. These results suggested that environmental factors, e.g.,
colony conditions, baseline inflammation level, influenced the response to inflammatory stimuli.   
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Figure 5.1 Thermal hyperalgesia induced by CFA injection. A. Thermal hyperalgesia, manifested by a 
shorter withdrawal latency post-CFA compared to pre-CFA, was compared between Harlan NIA (green) 
and Jackson lab (red) young Blk6 mice (n = 12/group). Thermal hyperalgesia lasted two days longer in 
Jackson mice compared to Harlan mice. B. Plots of thermal sensitivity in Harlan young (green) and old 
(red) Blk6 mice (n = 12/group). Thermal hyperalgesia was detected in young mice on day 1 post-CFA, 
but absent in old mice though withdrawal latency appears shorter on the first two days post-CFA. * - P < 
0.05, ** - P < 0.01 
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       In all three groups peak hyperalgesia occurred on 1 day post-injection. The greatest 
responses were detected in young mice from the Harlan colony, which showed a 39% decrease in 
withdrawal latency relative to baseline measure. Old mice from the Harlan colony and Jackson 
lab young mice only showed 27% and 22% decrease, respectively. Thus, CFA-induced 
inflammatory pain is of greater intensity and but shorter duration in young Harlan mice, but 
smaller and longer in old Harlan mice. These results suggest that aging results in decreased pain 
resulting from inflammation, which is consistent with clinical observations made in human.   
 
 
 
5.3 CHANNEL/RECEPTOR EXPRESSION IN THE PNS POST-CFA 
 
To identify whether abnormal expression of channels and receptors in the PNS associated with 
heat hyperalgesia induced by inflammation, we assayed relative levels of mRNAs encoding 
TRPV1, TRPV2, ASIC1, 2 and 3, and Nav1.8 in lumbar DRG after CFA injection. These 
channels are predicted to be involved in thermal, mechanical or chemical nociception and our 
previous screening showed some were decreased in the aged PNS. No change was measured in 
ASIC1, ASIC2 and TRPV2 mRNAs within 7 days post-CFA in either of the two age groups 
(data not shown). Nav1.8 expression decreased after 1d in old DRG though no significant change 
occurred in young DRG until 5 days post-CFA (Figure 5.2A). ASIC3, which is predominantly 
expressed in sensory neurons and is thought to mediate normal touch and pain sensation 
(Waldmann et al., 1997; Price et al., 2001), was decreased for 5 days after CFA in young animals 
while old animals did not show a change (Figure 5.2B). Although no difference was detected in 
the dynamic changes between young and old DRG after CFA, both Nav1.8 and ASIC3 mRNA 
levels in young DRG were significantly higher than in old DRG on day 1 post-CFA (Figure 
5.2A and B). Similarly, TRPV1 expression did not change in both young and old animals, but 
the overall abundance of TRPV1 mRNA was significantly lower in old DRG than in young DRG 
following CFA injection (Figure 5.2C). GFRα3 expression was also lower in old DRG although 
it was decreased in both young and old DRG after inflammation (Figure 5.2D). We further 
examined the levels of GFRα3 and TRPV1 protein in the sciatic nerve of CFA-injected mice. 
Both GFRα3 and TRPV1 were decreased in young and old animals compared with
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A                                                                            B 
                                Nav1.8        ASIC3 
 
         
                        CFA Injection (d)            CFA Injection (d) 
 
 
 C                                                                          D                     
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Figure 5.2 Relative mRNA expression in L2~5 DRG pre- and post-CFA injection (n = 4/group). A. 
Nav1.8 mRNA was increased from baseline level in young mice on day 5 (green asterisk) but decreased 
in old mice on day 1 (red asterisk) post-CFA, respectively. Note expression of Nav1.8 in DRG was higher 
than in old mice after CFA injection (black asterisks).  B. ASIC3 was decreased in young mice (green 
asterisks) and not changed in old after CFA injection. C. No changes in TRPV1 expression were found in 
either young or old DRG before and after CFA injection. But the expression level was consistently  
higher in young DRG compared to DRG from old animals after CFA injection (black asterisks). D. 
GFRα3 expression was decreased in both young (green asterisks) and old (red asterisks) mice after CFA 
injection. A higher level was measured in DRG from young animals than in old (black asterisks) after 
CFA. * - P < 0.05, ** - P < 0.01  
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A           GFRα3     B        GFRα3           
 
      
                                                                                           CFA Injection (d) 
 
 
 
C           TRPV1   D       TRPV1  
 
                           
                                                                                          CFA Injection (d) 
 
 
Figure 5.3 GFRα3 and TRPV1 protein in sciatic nerve pre- and post-CFA injection. A. Western blot of 
GFRα3 protein in sciatic nerve. GFRα3 was decreased in both young (Y) and old (O) mice on day 1, 3 
and 5 (1d, 3d, 5d) after CFA injection when compared to pre-injection level (Con). Each lane represents a 
nerve sample pooled from 4 young or 4 aged mice. B. Plot of band intensity measured from immunoblot 
shown in A. C. Western blot of TRPV1 protein in sciatic nerve shows a reduction of TRPV1 in both 
young (Y) and old (O) mice after CFA injection (1d, 3d, 5d) compared to pre-injection (Con). Each lane 
represents a sample pooled from 4 young or aged mice. D. Plot of band intensity measured from 
immunoblot shown in C.      
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baseline levels. Consistent with the findings at the mRNA level, TRPV1 and GFRα3 protein was 
also lower in pooled sciatic nerve of old animals than in young mice (Figure 5.3). The finding 
that Nav1.8, ASIC3 and TRPV1 channel expression was generally lower in the PNS of old mice 
compared with young animals following CFA-induced inflammation supports the hypothesis that 
they are involved with the decreased inflammatory pain behavior exhibited by old animals.  
 
 
 
5.4 GENE EXPRESSION OF ART AND NGF IN INFLAMED SKIN 
 
Previous studies have shown that ART and NGF increase following CFA-induced inflammation 
in skin (Malin et al., 2006). ART and NGF are postulated to be important in signaling pathways 
that mediate inflammation-induced thermal hyperalgesia through their regulation of TRPV1 
expression and activity. Given the linkage of these growth factors to pain signaling, we measured 
ART and NGF mRNA levels in hind-paw skin of young and old mice before and after CFA 
injection. We compared these measures to those made on the Blk6 mice obtained from the 
Jackson Laboratory. No significant difference was found in the baseline level of ART and NGF 
mRNA between young and old mice. However, ART mRNA level increased 2.5 fold in young 
mice (P < 0.01) and increased 3.9 fold in old mice (P < 0.05) on day 1 post-CFA injection, the 
day showing the peak behavioral response (Figure 5.4B). A decrease back to baseline in both 
young and old mice 3 days after CFA injection was then observed. In contrast to these changes, 
ART expression increased 10-fold (P < 0.01) in young mice from the Jackson lab on day 1 post-
CFA and remained elevated to 4-fold higher (P < 0.01) on day 4 (Figure 5.4A). NGF mRNA 
level decreased 2-fold in both young and old Harlan animals only on day 1 (P < 0.01) (Figure 
5.4D). In Jackson lab mice there was no change in NGF level in the CFA-injected hind-paw skin 
until day 7 after CFA (Figure 5.4C). These observations indicate that a dynamic change in ART 
and NGF mRNA level occurs in inflamed skin. The change in ART correlates with behavioral 
outcomes that follow CFA injection, suggesting that ART level in inflamed tissue may be more 
critical for inflammation-induced thermal hyperalgesia compared with NGF.  
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A           B   
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                     CFA Injection (d)                                                         CFA Injection (d) 
 
C                                                                          D 
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Figure 5.4 Relative expression of ART and NGF in inflamed footpad skin. A. ART expression was 
compared between young Harlan NIA (green) and Jackson (red) young Blk6 mice (n = 4/ group) before 
and after CFA injection. In Jackson mice ART increased 10-fold on day 1 and remained elevated at day 4 
(red asterisks), only a 2.5-fold change was measured in Harlan NIA mice post-CFA. B. ART level was 
similar between Harlan young (green) and Harlan old (red) mice (n = 4/group) prior to CFA injection. A 
2.5-fold increase in young skin (green asterisks) and a 3.9- fold increased in old skin (red asterisk), was 
found only on day 1 post-CFA. C. NGF expression in skin from Harlan NIA and Jackson young mice 
pre- and post-CFA injection (n = 4/ group). Note NGF was decreased on day 1 in Harlan mice (green 
asterisks) while increased on day 7 in Jackson mice (red asterisk). D. NGF expression in skin of Harlan 
young and old mice. A two-fold decrease was detected in both groups on day 1 post-CFA compared to 
pre-CFA (n = 4/ group) * - P < 0.05, ** - P < 0.01 
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5.5 GENE EXPRESSION OF LIF AND IL-6 IN INFLAMED SKIN 
 
Inflammation is a complex set of responses to injury and infection. Cytokines are critical 
mediators in regulating a variety of cellular and molecular events during inflammation. 
Cytokines are a group of proteins with similar structure and share subunits in their receptor 
complexes, such as gp130, and have overlapping functions. Considering that CFA-induced 
changes in behavioral responses and expression of genes associated with nociception were 
different between young and old mice, and much more different between Jackson and Harlan 
NIA Blk6 mice, we hypothesized that differences in the immune system could underlie these 
outcomes. We therefore compared gene expression of two inflammatory cytokines, leukemia 
inhibitory factor (LIF) and interleukin 6 (IL-6), in hind-paw skin of the three groups of mice 
before and after CFA injection. IL-6 and LIF can act in both pro-inflammatory and anti-
inflammatory ways, depending on inflammatory conditions (Gadient and Patterson, 1999). For 
example, during the acute phase reaction of inflammation, IL-6 can down-regulate the 
inflammatory response by suppressing pro-inflammatory IL-1 and TNF (Schindler et al., 1990). 
Both IL-6 and LIF have been found to play critical roles in inflammation-induced hyperalgesia 
(Banner et al., 1998; Opree and Kress, 2000).  
     
     In our studies no differences were found in the baseline level of IL-6 and ART mRNA in 
footpad skin of the three groups of mice (Figure 5.5A and C). However, the baseline level of 
LIF expression was 58% lower in Jackson mice and 33% lower in Harlan old mice when 
compared to it’s level in young mice from the Harlan NIA colony (P < 0.05) (Figure 5.5B). In 
addition, there was no remarkable change in LIF mRNA in either group until day 4 after CFA 
injection (Figure 5.6C and D). In contrast to LIF mRNA, IL-6 expression dramatically increased 
53-fold in Harlan young mice (P < 0.01), 44-fold in Harlan old mice (P < 0.05), and only 13-fold 
in Jackson mice (P = 0.06) on day 1 post-CFA (Figure 5.6A and B). Further regression analysis 
was done to identify whether these differences in cytokine level in footpad skin correlated with 
differences in ART expression and behavioral responses before and after CFA injection. This 
analysis showed that there was a linear relationship between baseline level of LIF mRNA in 
footpad skin and days of thermal hyperalgesia (P = 0.05) and a lower level of LIF correlated with 
longer hyperalgesia (Figure 5.7B). A linear relationship between fold-change of IL-6 and ART
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A           IL-6                                        
        
 
   B           LIF 
      
    
C         ART 
        
 
 
Figure 5.5 IL-6, LIF and ART mRNAs in footpad skin of naïve animals. A. No difference was detected 
in IL-6 expression in footpad skin among Jackson, young Harlan and old Harlan mice (n = 4 / group).  B. 
LIF expression was decreased 58% in Jackson and 33% in Harlan old mice compared to Harlan young 
mice. C. No difference was found in ART expression among these three groups. * - P < 0.05  
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A                                                                           B 
          IL-6          IL-6   
 
      
                      CFA Injection (d)                                                          CFA Injection (d) 
 
 
C                                                                           D 
           LIF         LIF 
 
       
                        CFA Injection (d)                                                         CFA Injection (d) 
 
 
Figure 5.6 Relative mRNA levels of IL-6 and LIF in inflamed footpad skin. A. IL-6 expression in young 
Harlan NIA and Jackson mice (n = 4/ group) before and after CFA injection. IL-6 mRNA in skin was 
increased 13-fold in Jackson and a 53-fold increase in Harlan mice on day 1 post-CFA. B.  IL-6 
expression was similar between Harlan young and old mice (n = 4/ group), and a 53-fold increase in 
young (green asterisks) and a 44-fold increase in old mice (red asterisk) were found on day 1 post-CFA 
compared to pre-CFA. C.  LIF expression in Harlan and Jackson young mice pre- and post-CFA injection 
(n = 4/ group). Note LIF was increased on day 4 in Jackson mice (red asterisk) but no change was found 
in Harlan mice. D. LIF expression in Harlan young and old mice. An increase in LIF was only detected in 
old mice  (red asterisks) post-CFA compared to pre-CFA (n = 4/ group) * - P < 0.05, ** - P < 0.01 
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A 
ART vs. IL-6 at CFA 1d 
 
 Fold Change of Skin IL-6 mRNA 
 
   
B 
Days of thermal hyperalgesia vs. baseline LIF 
  
Baseline Level of Skin LIF 
 
 
 
Figure 5.7 Correlation of IL-6 with ART and LIF with days of hyperalgesia A. On day 1 post-CFA the 
fold change of IL- 6 expression in inflamed skin linearly correlated with the change of ART expression 
(ART = 12.429 – 0.19 * IL-6, P < 0.05). B. The low baseline level of skin LIF expression was closely 
correlated with the 3-day thermal hyperalgesia induced by CFA in Jackson Blk6 mice (Days = 4.387 – 
3.427 * LIF, P = 0.05). 
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expression on day 1 after CFA with higher IL-6 increase related to lower ART increase (Figure 
5.7A), was also determined (P < 0.05). These findings suggest that LIF and IL-6 may have anti-
inflammatory effects manifested by shorter thermal hyperalgesia. Reduced hyperalgesia is 
related to higher baseline level of LIF and by lower ART expression and correlated with a higher 
level of IL-6 mRNA during CFA-induced inflammation.  
 
 
 
5.6 CONCLUSIONS 
 
To address the question of whether age modulates the degree of pathological pain and whether 
modulation of normal pain sensitivity by aging is involved in age differences in pathological 
pain, we studied thermal hyperalgesia in mice with CFA-induced peripheral inflammation.  We 
found that age not only decreased normal pain sensitivity but also inflammation-induced thermal 
hyperalgesia. Reduced behavioral responses to noxious heat are consistent with the molecular 
findings of decreased TRPV1 mRNA and protein in the PNS of aged animals following 
inflammation, which may result from decreased ART-GFRα3 signaling. These results also 
suggest that ART-GFRα3 signaling has a critical role in inflammatory pain. Preliminary studies 
also indicate that LIF and IL-6 act as anti-inflammatory factors that can regulate sensitivity to 
inflammatory pain, perhaps in conjunction with ART-GFRα3 signaling. Differences in 
behavioral sensitivity to inflammatory pain in Blk6 mouse line was also revealed and may be 
related to the “inflammatory tone” of the animals that is present prior to CFA injection. These 
findings strongly suggest that inflammation may be involved in the aging process of the PNS via 
effects on GFRα3-dependent neurotrophic signaling.  
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VI. RESULTS (3) 
EFFECTS OF ARTEMIN ON TRPV1-DEPENDENT RESPONSES IN DRG NEURONS 
 
 
 
Findings from our in vivo studies indicate involvement of ART-GFRα3 signaling in the aging 
process of the PNS. Previous studies have shown that ART/GFRα3 signaling modulates TRPV1 
expression and function. Therefore we investigated whether ART regulated TRPV1 function in 
aging neurons using calcium imaging. Resting DRG neurons typically have very low membrane 
permeability to Ca2+ in spite of a huge electrochemical driving force in favor of Ca2+ influx. The 
TRPV1 channel has much higher permeability to Ca2+ than other ions like Na+ and K+. Thus 
activation of TRPV1 induces large Ca2+ influx, and in turn results in rapid changes in 
intracellular Ca2+ concentration that can be detected using fluorescent Ca2+-binding indicators. 
These indicators are excited at slightly longer wavelengths in a Ca2+-free form than in a Ca2+- 
bound form. By measuring the ratio of fluorescence intensity at two excitation wavelengths, the 
concentration ratio of the Ca2+-bound indicator to the Ca2+-free can be determined, and then an 
accurate free Ca2+ concentration can be measured. Entering cells by diffusion, these indicators 
make it possible to monitor Ca2+ flux in a large number of individual cells simultaneously using 
a fluorescence microscope (Alberts et al., 1994). Though this approach lacks specificity, Ca2+ 
imaging is a helpful technique to assess activities of membrane Ca2+-permeable channels.  
 
 
 
      6.1 INTRODUCTION 
 
Activation of membrane voltage-gated calcium channels (VGCCs) or TRPV1 channels results in 
changes of intracellular free Ca2+ concentration and shape the intracellular Ca2+ transients. 
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Calcium movement reflects three major processes (Dedov and Roufogalis, 2000):  entry of 
extracellular Ca2+ through plasma membrane Ca2+ channels and release of Ca2+ from the internal 
Ca2+ stores of ER, intracellular Ca2+uptake by ER and mitochondria, and extrusion of Ca2+ by 
plasma membrane ATP-dependent Ca2+pumps and the Na+/Ca2+ exchangers. When the rate of 
Ca2+ influx and release is greater than the rate of Ca2+ uptake and efflux, the intracellular free 
Ca2+ concentration increases and shapes the rising phase of the Ca2+ transients; when the rate of 
Ca2+ influx and release is slower than the rate of Ca2+ uptake and efflux, the intracellular free 
Ca2+ concentration decreases and is represented by the declining phase of the Ca2+ transients; and 
the amplitude represents the maximal intracellular Ca2+ load. Analysis of the Ca2+ transients 
initiated by activation of plasma membrane Ca2+ channels alone provides indirect evidence about 
functional properties of these channels.  
 
       An age-related difference in Ca2+ signaling in the nervous system is a decreased capacity of 
aged neurons to maintain a steady resting state following a stimulation-evoked Ca2+ response. 
The calcium hypothesis of neuronal aging postulates that age-dependent dysregulation of 
calcium homeostasis that result in changes in the free intracellular Ca2+ concentration account for 
changes in neuronal function (Biessels and Gispen, 1996). The mechanisms underlying age-
dependent dysregulations of Ca2+ homeostasis have been explored in detail in both the PNS and 
CNS (Pottorf et al., 2002; Toescu and Verkhratsky, 2003, 2004; Toescu et al., 2004). Several 
mechanisms contribute to this age-related decrease in Ca2+ homeostasis, such as increased Ca2+ 
entry due to increased VGCC expression, decreased Ca2+ uptake by ER and mitochondria, and/or 
decreased activity of plasma membrane ATP-dependent Ca2+ pumps (Kirischuk et al., 1992; 
Hartmann et al., 1996; Kirischuk and Verkhratsky, 1996; Xiong et al., 2002; Murchison et al., 
2004; Vanterpool et al., 2005). The most common and constant observation is decreased 
mitochondrial Ca2+ uptake due to alteration of mitochondria function with aging. Ca2+ uptake by 
mitochondria not only determines Ca2+ signals but also regulates neuronal excitability (Nowicky 
and Duchen, 1998; Vanden Berghe et al., 2002). Studies have shown a critical role of 
mitochondria in intracellular Ca2+ signaling in DRG neurons (Dedov and Roufogalis, 2000; 
Dedov et al., 2001; Shishkin et al., 2002), suggesting that age-induced functional damages to 
mitochondria might have a significant effect on sensory function.  
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       Although the mechanisms underlying age-related changes in intracellular Ca2+ signaling 
have been well investigated, less is known about membrane Ca2+-permeable channels that trigger 
the Ca2+ signals (Griffith et al., 2000; Toescu and Verkhratsky, 2000). In this study we were 
particularly interested in the Ca2+-permeable TRPV1 channel. To investigate whether functional 
properties of TRPV1 in primary sensory neurons change with aging, we compared the Ca2+ 
transients induced by application of 1uM capsaicin (CAP), a highly specific TRPV1 agonist, to 
DRG neurons from 2~4 month old and 15~18 month old male mice. We found that CAP-induced 
Ca2+ transients were slower and longer in aged DRG neurons. We also tested whether addition of 
ART to growth media altered TRPV1 activation in neurons of aged mice. Our findings show that 
ART has less of an effect on TRPV1 activity in aged neurons compared to young neurons, 
suggesting that aging does fundamentally alter the physiological activity of TRPV1.  
 
 
 
6.2 CAP-INDUCED RESPONSES DEPEND ON MEMBRANE TRPV1 
 
Capsaicin is a specific agonist of TRPV1 and increases intracellular Ca2+ by binding and opening 
plasma membrane TRPV1, which results in extracellular Ca2+ influx through this receptor. It may 
also act directly on ER and mitochondria and thereby induce Ca2+ release from internal stores. 
We first tested if application of 1uM CAP for 5s to DRG neurons had a specific effect on plasma 
membrane receptors but no other side effects. We found that brief application of a small amount 
of CAP to both young and old neurons induced very small responses in the absence of 
extracellular Ca2+ but robust responses in the presence of Ca2+ (Figure 3.1A), indicating that  
activation of plasma membrane TRPV1 by CAP triggered Ca2+ transients that were followed by a 
cascade of Ca2+-buffering mechanisms.  We then went on to compare amplitude (ΔF), latency 
(Tmax) and half-decay time (T1/2) of CAP-induced Ca2+ transients between young and old neurons 
to determine if functional properties of TRPV1 significantly change with aging. These data will 
be used in design of future detailed electrophysiological studies of aging neurons. 
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6.3 EFFECTS OF ARTEMIN ON CAP RESPONSES IN DRG NEURONS  
 
To determine how ART regulates TRPV1 function in DRG neurons of Harlan NIA Blk6 mice, 
we first compared CAP responses in young neurons pooled from all levels of DRG cultured 
overnight (18~24h) in media containing 250ng/ml ART to neurons in media containing no 
growth factor or 50ng/ml NGF. CAP responsive neurons [CAP(+)]  are defined as cells with one 
change in amplitude (ΔF) of Ca2+ transients greater than 0.2 following three separate CAP 
applications (Figure 3.1B). Compared with control neurons (CON) grown without any growth 
factors, neither ART nor NGF increased the percentage of CAP(+) neurons (CON, 32%; ART, 
29%; NGF, 33%) among the total neurons (CON, n = 164; ART, n = 166; NGF, n = 167) 
investigated and responsive to 50mM KCl (Table 6.1). However, among all the CAP(+) cells 
(CON, n = 52; ART, n = 48; NGF, n = 55), ~20% in CON and NGF (CON, n = 11; NGF, n = 11)  
did not respond to the first CAP exposure (CAP1), whereas only ~10% in ART (n = 5) were not 
responsive to CAP1, i.e., ~90% of ART-treated CAP(+) cells (n = 43) were CAP1 responsive 
[CAP1(+)] (Table 6.1). The high percentage of CAP1 responders in ART media indicates that 
ART may enhance TRPV1 activation by the first CAP application.  
 
       
 
Table 6.1 Effect of ART and NGF on percentage of CAP (+) neurons in young mice. DRG 
neurons isolated from young animals were incubated in media containing ART (ART) or NGF 
(NGF) or in media without growth factors (CON) overnight. The following day neurons were 
briefly exposed to 1uM CAP every ten minutes for three times (Figure 3.1B). CAP (+) (CAP-
responsive) neurons are neurons responsive to either one of the three CAP applications. CAP1 
(+) neurons are neurons that can respond to the first CAP exposure. 
                  Total                   CAP(+)             % of CAP(+)             CAP1(+)              % of CAP1(+) in 
                neurons (n)         neurons (n)          in total neurons         neurons (n)            CAP(+) neurons  
CON  164   52   32%   41   79%  
ART  166   48   29%   43   90% 
NGF  167   55        33%   44   80% 
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A      B 
         ΔF 
                                                                                                          
       CON       ART       NGF 
 
      
C      D 
       Tmax       T1/2 
     
        CON        ART        NGF      CON      ART       NGF 
 
 
Figure 6.1 Effect of ART and NGF on CAP1 responses in young neurons. A. Parameters of Ca2+ 
transients induced by CAP (see section 3.4.4 for detailed explanation). B. NGF in media increased the 
mean amplitude (ΔF) of Ca2+ transients but ART did not. C. The presence of ART or NGF in media did 
not affect the mean latency to maximal responses (Tmax). D. NGF in media decreased the mean half-decay 
time (T1/2) of Ca2+ transients but ART did not relative to control value. CON, n = 32; ART, n = 24; NGF, 
n = 32; * - P < 0.05, ** - P < 0.01  
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Next we looked at whether ART or NGF affected CAP1-induced Ca2+ transients in young 
neurons (Figure 6.1). Surprisingly ART (n = 24) had no effect on ΔF (0.9 ± 0.07) or T1/2 (71 ± 
18s) while NGF (n = 32) significantly increased ΔF (1.51± 0.16, P < 0.01) and decreased T1/2 (25 
± 4s, P < 0.05) of CAP1-induced Ca2+ transients compared with control neurons (ΔF, 0.84± 0.05; 
T1/2, 87 ± 20s; n = 32) (Figure 6.1B and D). Neither ART nor NGF affected Tmax (CON, 17 ± 
1.3s; ART, 14.2± 1.1s; NGF, 15±1.5s) (Figure 6.1C). These findings indicate that long-term 
(18~24h) treatment with ART does not change physiological properties of TRPV1-dependent 
Ca2+ signals in CAP1-responsive DRG neurons, but NGF alone can enhance CAP1 responses.   
 
 
 
6.4 EFFECTS OF ART ON CAP RESPONSES IN AGED NEURONS 
 
To determine if ART or NGF modulate TRPV1 responses differentially in DRG neurons from 
young and old mice, we compared CAP responses in young and old neurons incubated in growth 
media containing both 250ng/ml ART and 50ng/ml NGF with those in neurons cultured in media 
containing 50ng/ml NGF alone. For studies of old neurons, cultures grown without growth 
factors could not be used for controls since old neurons do not survive in media without NGF. 
Thus for these studies, all neurons (young and old) were plated with 50ng/ml NGF. ART plus 
NGF (A+N) significantly increased the percentage of CAP-responsive cells in both young (45%, 
P < 0.01) and old animals (42%, P < 0.01) compared with NGF alone (young, 33%; old, 30%) 
(Table 6.2). But no difference in the percentage of CAP (+) neurons was detected between 
young and old animals, which is consistent with the immunolabeling study showing no 
difference in the percent of TRPV1 neurons in young and old ganglia (Figure 4.3B).  
 
       As shown in Table 6.1, ART alone may increase the percentage of CAP1-responsive cells in 
cultures of young neurons. In addition, exposure of young neurons to ART plus NGF 
significantly increased the percentage of CAP1 (+) neurons (94%, P < 0.05) compared with NGF 
alone (80%). In contrast to these findings, no significant increase in CAP1 responsive neurons 
was found in cultures from aged mice (A+N, 87%; NGF, 81%) (Table 6.2). Taken together,
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Table 6.2 Effect of ART on CAP (+) neurons in young and old mice. The protocol used is 
similar to the one described in Table 6.1 except that DRG neurons from young and old animals 
were incubated in media containing NGF or NGF plus ART overnight. 
                  Total                   CAP(+)             % of CAP(+)             CAP1(+)              % of CAP1(+) in 
                neurons (n)         neurons (n)          in total neurons         neurons (n)            CAP(+) neurons  
Y(N)  167   55   33%   44   80%  
Y(NA) 117   53   45% **  50   94% * 
O(N)  210   62        30%   50   80% 
O(NA) 197   83   42% **  72   87% 
 
Note: Y(N) or Y(NA) - young neurons grown in media containing NGF or NGF plus ART 
          O(N) or O(NA) – old neurons grown in media containing NGF  or NGF plus ART 
          * - P < 0.05,  ** - P < 0.01, χ2 test, compared NGF plus ART to NGF group of the same age. 
 
 
 
these studies indicate that ART has less effect on TRPV1 activation in old neurons, and this 
reduction may be related to the decreased level of GFRα3 in ganglia of aged animals.  
 
       To determine whether aging affects TRPV1 responsiveness, we compared CAP1-induced 
Ca2+ transients in young (n = 32) and old (n = 34) neurons cultured in media with NGF alone. 
Though there was no difference in the amplitude between young and old cells (young, 1.51 ± 
0.16; old, 1.31 ± 0.1) (Figure 6.2B), it took old neurons about twice as long to reach the peak 
responsiveness (Tmax, young, 14.7 ± 1.5s; old, 26.1 ± 3.2s; P < 0.01) (Figure 6.2A and C) as well 
as to recover (T1/2, young, 25 ± 4s; old, 58 ± 12s; P < 0.05) (Figure 6.2A and D). This suggests 
that CAP-induced activity of plasma membrane TRPV1 is functionally changed with aging. To 
investigate ART effects on age-related changes in CAP-induced Ca2+ transients, we further 
analyzed young (n = 30) and old CAP1 (+) neurons (n = 38) cultured in media containing both 
ART and NGF. Similar to NGF alone, young neurons reached the maximal response in half the 
time taken by old neurons (Tmax, young, 15 ± 1.1s; old, 31 ± 3.9s; P < 0.01) (Figure 6.2C). 
However, in the presence of ART and NGF the mean ΔF was significantly lower in young 
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A      B  
           
                         Y(N)    Y(NA)   O(N)   O(NA) 
 
 
C      D 
           Tmax      T1/2 
     
                   Y(N)   Y(NA)   O(N)   O(NA)                                         Y(N)    Y(NA)   O(N)   O(NA) 
 
 
Figure 6.2 Effect of ART on CAP1 responses in young and old neurons. The same protocol was used as 
the one described in Figure 6.3. A. Comparison of a typical CAP1-induced Ca2+ transient in young and 
old neurons. B. ART and NGF in media decreased the mean ΔF of Ca2+ transients in young neurons 
compared to young in NGF (green asterisks) or old neurons (black asterisks). C. The mean latency to 
maximal responses (Tmax) in young neurons was shorter than in old neurons (black asterisks), which was 
not affected by ART. D. The mean half-decay time (T1/2) of Ca2+ transients in young neurons in NGF 
alone was shorter than in old neurons (black asterisk). ART in media increased T1/2 in young neurons 
(green asterisk) but not in old neurons. Y(N) (n = 32) or Y(NA) (n = 30) - young neurons grown in media 
containing NGF or NGF plus ART,  O(N) (n = 34) or O(NA) (n = 38) – old neurons grown in media 
containing NGF or NGF plus ART,* - P < 0.05, ** - P < 0.01  
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neurons (young, 1.0 ± 0.06; old, 1.38 ± 0.1; P < 0.01) (Figure 6.2B) while no difference was 
found in recovery between the two age groups (Figure 6.2D). ART plus NGF treatment also 
decreased the amplitude and increased the recovery time in young neurons compared with NGF 
treatment alone, but no changes were found in old neurons with or without ART (Figure 6.2B 
and D). These results suggest that ART has less of an effect on TRPV1 activation by CAP in 
DRG neurons isolated from aged mice.  
 
 
 
6.5 EFFECTS OF AGING ON KCL-INDUCED RESPONSES 
  
The relationship between calcium influx via membrane VGCCs and neuronal function in aging 
has been well studied in the nervous system. Consistent findings in cultured aged neurons 
include increased calcium influx via high threshold VGCCs, delayed recovery of intracellular 
Ca2+ and decreased neuronal excitability. To determine whether ART has effects on age-related 
changes in VGCC-dependent Ca2+ signals, we first analyzed KCl-induced Ca2+ transients in 
CAP1-sensitive young (n = 18) and old (n = 20) neurons incubated in NGF-containing media. 
Longer recovery was found in KCl-induced Ca2+ transients in old neurons (T1/2, young, 10.1 ± 
3.7s; old, 52.1 ± 15.5s; P < 0.05) (Figure 6.3B), indicating that functional properties of VGCCs 
may be altered with aging, which is consistent with previous studies. There was no change in 
amplitude between young and old cells (young, 1.36 ± 0.12; old, 1.36 ± 0.11) (Figure 6.3A). 
However, in the presence of both ART and NGF in the growth media, the mean amplitude of 
KCl-induced Ca2+ transients in 21 young neurons analyzed was significantly lower than in 23 old 
neurons (ΔF, young, 1.03 ± 0.05; old, 1.37 ± 0.12; P < 0.05). No difference was found in T1/2 
between young and old neurons (young, 19 ± 4s; old, 21 ± 5s) (Figure 6.3A and B), indicating 
that ART also has an effect on VGCC-dependent Ca2+ transients. Further analysis showed that in 
young neurons ART plus NGF treatment also decreased the amplitude of Ca2+ transients 
compared to NGF treatment alone (P < 0.05) whereas no difference was found in old neurons 
(Figure 6.3A). More interestingly, ART plus NGF significantly decreased T1/2 in old neurons (P 
< 0.05) but had no effect on young neurons (Figure 6.3B). These findings show that age-related 
changes in DRG neurons alter the effect of ART on VGCC activation and/or expression.  
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Figure 6.3 KCl-induced Ca2+ transients in CAP1 (+) young and old neurons. A. ART decreased the mean 
ΔF of Ca2+ transients in young neurons relative to those found in young neurons grown in NGF (green 
asterisks) or old neurons (black asterisks). B. The mean half-decay time (T1/2) of Ca2+ transients in old 
neurons was longer than in young neurons (black asterisk). ART decreased T1/2 in old neurons (red 
asterisk) but not in young neurons. Y(N) (n = 18) or Y(NA) (n = 21) - young neurons grown in media 
with NGF or NGF plus ART,  O(N) (n = 20) or O(NA) (n = 23) - old neurons grown in media with NGF 
or NGF plus ART, * - P < 0.05 
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6.6 EFFECTS OF ARTEMIN ON TRPV1 FUNCTIONAL PROPERTIES 
 
TRPV1 can be desensitized by repetitive application of capsaicin.  ART, NGF as well as the 
nucleotide ATP can reverse repetitive CAP-induced desensitization and increase TRPV1 
activation (Bonnington and McNaughton, 2003; Moriyama et al., 2003; Malin et al., 2006). 
Desensitization of TRPV1 following its activation and potentiation by ATP is critical in blocking 
or promoting pain transmission, especially during inflammation. To test if ART alone can 
modulate these functional properties of TRPV1, we measured TRPV1 desensitization by 
repetitive application of CAP and potentiation by ATP in young neurons grown overnight in 
media either containing no growth factor or ART alone (Figure 6.4). Without growth factors the 
CAP2 responses in young DRG neurons (n = 37) showed typical desensitization with 39% 
decrease in the mean response amplitude compared to CAP1 responses (P < 0.01) (Figure 6.4A 
and B). Potentiation of the CAP3 responses by ATP compared to CAP2 responses also occurred 
(P < 0.05) with 30% increase in response amplitude in cultures without growth factors (Figure 
6.4C and D). In the presence of ART (n = 40) reduced desensitization occurred to only 19%, 
whereas potentiation by ATP occurred to only 12%, and neither desensitization nor potentiation 
was significant (Figure 6.4B and D). These changes indicate that ART alone in the media can 
inhibit TRPV1 desensitization as well as its potentiation by ATP.    
 
       To determine if age modulates desensitization and potentiation of CAP responses by ATP, 
young (n = 39) and old neurons (n = 50) cultured in NGF-containing media were compared 
(Figure 6.5). TRPV1 was desensitized following CAP activation by 19% in young neurons and 
20% in old neurons. In NGF-only cultures ATP potentiation was increased 25% in young 
neurons and 32% in old neurons. Thus, young and old neurons showed comparable TRPV1 
desensitization and potentiation in the presence of NGF. To test if ART induces age-related 
differences in these properties of TRPV1, young (n = 39) and old neurons (n = 43) cultured in 
media containing both ART and NGF were compared (Figure 6.5). ART plus NGF treatment did 
not significantly affect the desensitization shown by NGF alone, since a 17% decrease in young 
neurons and a 26% decrease in old neurons occurred. It did, however, dramatically decrease 
TRPV1 potentiation by ATP, where only a 4% and a 9% increase were measured in young and 
old neurons, respectively (Figure 6.5B). Similar to NGF alone, NGF and ART affected TRPV1
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Figure 6.4 Effect of ART on TRPV1 desensitization and potentiation. Young DRG neurons were 
incubated in media containing ART (ART, n = 40) or in media without growth factors (CON, n = 37) 
overnight. A. Repetitive application of CAP decreases CAP response indicating TRPV1 is desensitized. 
B. In CON the CAP2 response is significantly reduced compared to CAP1, whereas with ART in media 
no significant difference is measured between CAP1 and CAP2 responses . C. Following ATP application 
(red arrow), CAP3 response is increased indicating TRPV1 is potentiated. D. In CON the CAP3 response 
is significantly increased compared to CAP2, while with ART in media no significant increase in CAP3 
response is detected compared to CAP2. * - P < 0.05, ** - P < 0.01, paired t-test.  
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Figure 6.5 TRPV1 desensitization and potentiation in young and old neurons incubated in media 
containing NGF or NGF plus ART overnight. A. TRPV1 desensitization. With ART in media both young 
and old neurons show TRPV1 desensitization manifested by significantly reduced CAP2 responses 
compared to CAP1. B. TRPV1 potentiation by ATP. Age did not affect CAP3 potentiation by ATP 
though ART inhibited CAP3 potentiation in both young and old neurons. Y(N) (n = 39) or Y(NA) (n = 
39) – young neurons grown in media containing NGF or NGF plus ART,  O(N) (n = 50) or O(NA) (n = 
43) – old neurons grown in media containing NGF  or NGF plus ART,  * - P < 0.05, paired t -test 
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response in young and old neurons to equal degree. Thus, age does not modulate TRPV1 
desensitization and potentiation. It should be mentioned that not all of the analyzed neurons 
showed potentiation or desensitization of TRPV1 and no difference in the percentage of these 
neurons was found with aging. We also found that acute exposure to ART potentiated CAP 
responses in both young and old neurons growing in NGF-containing media. More studies are 
required to determine if there are age differences in the extent of potentiation and the percentage 
of potentiated neurons under these acute conditions.  
 
 
 
6.7 CONCLUSIONS 
 
To determine whether ART regulated TRPV1 function, CAP responses in young neurons grown 
overnight in media containing no growth factor, ART or NGF alone were compared. We found 
that NGF alone did increase CAP1 responses in young neurons compared to neurons grown 
without NGF, suggesting NGF enhances TRPV1 function in vitro. In contrast to the effect of 
NGF, ART alone rarely increased CAP1 responses and also decreased TRPV1 potentiation by 
ATP, indicating that overnight culture in ART may inhibit TRPV1 function in vitro. To 
determine whether age modulates the effect of ART on TRPV1 function, young and old neurons 
grown in media containing ART plus NGF or NGF alone were compared. We found that ART 
plus NGF, compared with NGF alone, decreased CAP1 responses in young neurons and 
inhibited TRPV1 potentiation by ATP in both young and old neurons, further supporting the 
inhibitory effects of ART on TRPV1 activity. These findings indicate that chronic exposure to 
ART may have an analgesic effect on TRPV1-mediated sensation. Decreased GFRα3 protein 
found in aged DRG may contribute to the age-modulated effects of ART on TRPV1 function and 
expression. 
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VII. DISCUSSION AND CONCLUSIONS 
 
 
 
Somatosensory function has been shown to generally decrease with aging. Experiments of this 
dissertation investigated possible mechanisms that may underlie this age-related decline in 
sensory perception. Our studies reveal a complex interaction between growth factor and receptor 
expression, the level of ion channel expression and activity and expression of inflammatory 
proteins. The data suggest that a decline in expression of the artemin receptor GFRα3 in sensory 
ganglia occurs with aging and may underlie at least some aspects of the changes in sensory 
function. Similar to what has been shown for NGF, we propose that the growth factor artemin 
has two roles: it functions as a survival and differentiation factor during embryonic and postnatal 
development and as a modulator of afferent sensitivity in the adult. It is postulated that artemin 
signaling through the GFRα3 receptor declines in aging neurons, and this decline leads to down-
regulation of TRPV1 translation and functional deficits in TRPV1 activation, which leads to 
impaired nociceptive signaling. Our findings also suggest that the “inflammatory tone” of an 
animal may contribute to pain threshold. Thus, the reduced pain sensitivity exhibited by the 
Harlan Blk6 mice relative to Blk6 mice from Jackson labs following CFA injection, may relate 
to the difference in expression of inflammatory mediators such as IL-6 and LIF. In addition, the 
increased expression of inflammation and immune related genes in ganglia of aged mice, 
determined using Affymetrix analysis, may contribute to the reduced sensitivity of older mice.  
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7.1 MOLECULAR BASIS FOR THERMAL SENSITIVITY IN AGING 
 
7.1.1 TRPV1 expression and thermal sensitivity in aging   
 
In our behavioral studies we show that a decrease in thermosensation occurs in naïve mice that 
are either 16 mo or 2 yr-old. Prior studies of age-associated thermal insensitivity in rodents have 
focused on the rat (Gagliese and Melzack, 2000). Outcomes of these studies are quite varied, 
with some reporting reduced thresholds in aged rats and others showing no change. These 
different outcomes could reflect the rat strain tested or variability in the test used (tail flick and 
hot plate) to measure thermal responsiveness. In this study we took great care to minimize 
possible environmental variables, i.e., animals were acclimated to the testing environment, they 
were tested at the same time of day by the same investigators and we used a radiant heat source 
applied to a discrete area of the foot with responses timed within 0.1 s (i.e., the Hargreaves' test). 
As in all behavioral studies of aged animals, a potential caveat is whether motor abilities are 
impaired in older animals that could slow an avoidance reflex. Although this remains a 
possibility, the 16-month and 2-year old animals used in this study showed no discernable 
impairment in mobility or motor control. 
 
       To determine whether the reduced detection of noxious heat in aging mice correlates with 
changes in ion channel expression in DRG and axons that project to the skin, we measured the 
relative level of TRPV1 in young and old mice. TRPV1, a heat-sensitive channel, is required for 
detection of heat at high temperatures (≥ 52°C) in vivo and essential for thermal hyperalgesia 
induced by inflammation (Caterina et al., 2000; Davis et al., 2000; Ji et al., 2002). Our findings 
support a mechanism whereby a reduced level of TRPV1 contributes to a decrease in thermal 
sensitivity observed in both naïve and inflamed aging mice. This reduction in TRPV1 appeared 
to be more prominent in neurons at lumbar levels that project to the limbs, supporting the notion 
that long axonal length is a hindrance to transport of substances important for normal neuron 
function in aged animals (Caterina et al., 1997).  
 
       Under normal condition both 16-month and 2-year old mice exhibited reduced levels of 
TRPV1 protein in DRG neurons, though no change in the overall number of TRPV1-positive 
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neurons occurred. This suggests that changes in protein expression that contribute to sensory 
perception begin at midlife. This decrease in TRPV1 was greater in the 2-year old group 
indicating a progressive decline. Reduced levels of TRPV1 were also found in peripheral nerves 
of aged animals suggesting TRPV1 transport is also less efficient. Coincident with these 
processes, it is also possible that some TRPV1-positive fibers are lost with age due to neuronal 
death or degeneration of afferents in the periphery. Indeed, the lower density of immunolabeled 
TRPV1-positive fibers in tibial and cutaneous nerves would support this possibility. However, 
anatomical studies have indicated that loss of afferents in the skin becomes most prominent only 
in very old animals (Ceballos et al., 1999). Only a modest afferent loss would therefore be 
expected at 15 months of age, the time at which a reduction in TRPV1 protein was measured in 
this study. Consistent with the findings under normal conditions, impaired thermal hyperalgesia 
and lower level of TRPV1 proteins in peripheral nerves were also detected in aged mice 
following CFA-induced inflammation, supporting the requirement of TRPV1 for thermal 
sensitivity following inflammation. Further analysis indicates that the decreased TRPV1 protein 
might be related to an increased level of inflammation. This possibility is supported by the CFA-
induced reduction of TRPV1 in the PNS of both young and aged mice. Interestingly, our results 
show that the reduction in TRPV1 in the DRG occurs only at the translational level. This mode 
of TRPV1 regulation is not unique since translational regulation of TRPV1 expression has also 
been reported in rat following inflammation of the footpad (Ji et al., 2002).  
 
7.1.2 Functional properties of TRPV1 in DRG neurons in aging   
 
Based on our behavioral and molecular findings in the PNS of aged mice, we hypothesized that 
age-related functional changes in TRPV1 might also occur. To test this hypothesis we examined 
TRPV1 activity in dissociated DRG neurons. We used Ca2+ imaging in order to monitor a large 
number of individual cells simultaneously. Physiological properties of TRPV1, a Ca2+-permeable 
channel, were determined by analyzing TRPV1-dependent Ca2+ transients induced by application 
of capsaicin, a specific agonist of TRPV1. A study of rat DRG neurons has shown that about 
97% of CAP-responsive neurons are also sensitive to heat although only 86% of heat-sensitive 
neurons respond to CAP (Savidge et al., 2001). So activation of TRPV1 by CAP reflects heat-
activated TRPV1 function to a large degree although the molecular mechanisms of CAP 
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activation may be different from heat activation. Consistent with the finding that age does not 
affect the percent of TRPV1 neurons in DRG, we did not find a difference in the percentage of 
CAP–responsive cells between young and old animals in vitro. However, the percentage of CAP 
(+) cells (~30%) detected in vitro, which is similar to the percent of CAP-responsive neurons 
found in mouse trigeminal ganglia (Simonetti et al., 2006), is less than the percent of 
immunolabeled TRPV1-positive neurons (~50%) found in our in vivo studies and other in vitro 
studies (Simonetti et al., 2006), suggesting that some TRPV1 positive neurons may be 
functionally insensitive to CAP application.  
 
       Despite the fact that the percent of capsaicin-responsive neurons did not change with aging, 
analysis of Ca2+ transients did reveal changes in that the rising and recovery of CAP- induced 
Ca2+ transients in old neurons were significantly slower than in young neurons. The longer 
latency in reaching maximal response in old neurons was correlated with, and might also account 
for, the behavioral outcome where old animals took longer to withdraw from noxious heat. 
Because CAP is lipophilic and membrane permeable, and can pass through the cell membrane 
and act on binding sites in the cytosolic domain of TRPV1 (Tominaga and Tominaga, 2005), 
such an apparent time lag between CAP uptake and peak response in aging neurons might be 
explained in part by changes in membrane properties of old neurons. As mentioned before, 
neurons are enriched in unsaturated lipids, which are prone to oxidative damage, and 
accumulation of lipid damage can decrease fluidity and increase rigidity of the plasma 
membrane. These changes may lead to a decline in membrane receptor-mediated signaling and in 
turn a decrease in function (Shigenaga et al., 1994). The extended recovery of Ca2+ transients 
exhibited by old neurons may also reflect well-established age-related changes in cellular 
properties. In this case, slow recovery of Ca2+ level may be due to age-induced mitochondrial 
dysfunction, which causes intracellular Ca2+ dysregulation (Toescu, 2000; Toescu et al., 2000).  
 
       Although it is possible that age-related membrane and mitochondrial damage contribute to 
the slow and long Ca2+ transients induced by CAP in old neurons, we cannot rule out the 
possibility that the properties of TRPV1 receptor activation and inactivation also change with 
aging. Two types of CAP-induced inward currents: one with rapid activation (RA) and rapid 
inactivation (RI) and one with slow activation (SA) and slow inactivation (SI), have been 
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described in rat trigeminal ganglia. Both currents are about the same magnitude and CAP-
responsive neurons have been shown to contain either one or both of the two types of currents 
(Marsh et al., 1987; Liu and Simon, 1994). Our results suggest that SA-SI currents may be more 
predominant in old neurons while RA-RI currents predominate in young neurons. 
        
       Phosphorylation of TRPV1 on certain amino acid residues is required for CAP binding, 
providing a way in which to control activation of ligand-gated channels (Jung et al., 2004). 
Selective phosphorylation of TRPV1 might explain why only some immuno-labeled TRPV1-
positive neurons were activated by CAP. Slow activation of TRPV1 by CAP binding in old 
neurons might arise from reduced kinase phosphorylation or increased phosphatase action on 
TRPV1. Mechanisms underlying inactivation of TRPV1 vary with different kinetic components. 
Rapid inactivation depends on Ca2+ influx through TRPV1 while slow inactivation does not 
(Tominaga and Tominaga, 2005). Some studies have found that Ca2+-dependent phosphorylation 
of TRPV1 regulates rapid inactivation while PKA-dependent phosphorylation of TRPV1 
mediates slow inactivation (Docherty et al., 1996; Bhave et al., 2002). Thus, phosphorylation of 
TRPV1 by different mechanism seems to control TRPV1 activity through the dynamic balance 
between phosphorylation and dephosphorylation (Mohapatra and Nau, 2005; Jeske et al., 2006), 
which might be significantly altered during age. Further electrophysiological and 
phosphorylation assay studies are required to test this possibility.  
 
7.1.3 Contribution of other factors to reduced thermal sensitivity in aging  
 
7.1.3.1 Contribution of ion channels other than TRPV1. Although our studies suggest that down-
regulation of TRPV1 expression and function in the PNS with age may contribute to decreased 
thermal sensitivity, especially decreased inflammatory thermal hyperalgesia, it should be 
mentioned that TRPV1 knockout mice and isolated nociceptors from them have normal heat 
responses (Caterina et al., 2000; Davis et al., 2000; Woodbury et al., 2004). Therefore TRPV1 is 
not the only channel involved in thermal nociception and a decrease in TRPV1 alone may not be 
enough to cause impaired thermal sensitivity in aged mice.  However, in addition to decreased 
TRPV1 expression, the relative levels of mRNAs encoding the Nav1.8 and Nav1.9 sodium 
channels and Cav2.2 calcium channel were also reduced in DRG of old mice. These channels are 
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preferentially expressed by nociceptors, many of which are TRPV1 positive and responsive to 
heat. In rat DRG about 66% of TRPV1 neurons express Nav1.8 and 55% of TRPV1 cells co-
express Nav1.9 (Amaya et al., 2000). In vitro studies show that 80% of CAP-responsive neurons 
express Nav1.8 mRNA, and a splicing variant of Cav2.2, e37a mRNA, is present in 55% of CAP-
responsive neurons while only 17% of non-responsive cells are positive (Bell et al., 2004). 
Although the Nav1.8, Nav1.9 and Cav2.2 channels are not directly activated by heat, they are 
essential for generation and propagation of the action potential and neurotransmission in the 
nociceptive pathway that follows a heat stimulus. Nav1.8 channels, in particular, contribute more 
than 50% of the inward current underlying the depolarizing phase of the action potential in cells 
in which they are present, and endow cells with the capability to generate sustained trains of 
action potentials in response to long-lasting stimuli (Renganathan et al., 2001). Thus, the 
reduction in Nav1.8, Nav1.9 and Cav2.2 levels in the DRG, though modest, could impair nerve 
function. Likewise, modest reduction of TRPV channel proteins in the DRG cell bodies and 
afferents could alter the heat threshold of firing.  
 
7.1.3.2 Contribution of glial and supporting cells. Supporting glial cells such as satellite cells 
and Schwann cells are also important for maintenance of normal neuronal function. For example, 
selective disruption of the ErbB4 receptor in adult non-myelinating Schwann cells causes loss of 
unmyelinated nerve fibers and impaired heat sensitivity (Chen et al., 2003). ETRB, an endothelin 
receptor, is specifically expressed in DRG satellite cells and nonmyelinating ensheathing 
Schwann cells and is also involved in signaling nociceptive events in peripheral tissues (Pomonis 
et al., 2001). A decreased level of ETRB and myelin mRNAs were expressed in DRG from aging 
mice, indicating that aging also compromises glial function which may modify pain sensitivity. 
 
 
 
7.2 ARTEMIN-GFRα3 SIGNALING IN AGING AND INFLAMMATION 
 
Trophic factor reduction in aging has been hypothesized to influence neuronal phenotype, e.g., 
by altering channel and peptide expression and thereby causing loss of functional sensitivity. 
Trophic signaling may decline due to structural changes in axons that impair retrograde (and 
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anterograde) transport of growth factors and their receptors. In the ganglia, paracrine and 
autocrine trophic signaling may also be affected. Indeed, decreases in Trk tyrosine kinase 
receptors (which bind the neurotrophins NGF, NT3, NT4 and BDNF) have been reported in 
sensory neurons of the 30-month old rat, supporting the notion that trophic signaling declines 
with age (Bergman et al., 1999a). Although an age-related reduction may not be sufficient to 
cause neuronal death, it may compromise regulation of gene expression. To understand the 
molecular mechanisms underlying down-regulation of TRPV1 expression and function in the 
PNS by aging, we investigated whether age modulated NGF, ART and receptor expression in the 
PNS. In mouse DRG about 67% of TRPV1 neurons express the ART receptor GFRα3, 80% of 
which are also NGF receptor TrkA-positive, suggesting that NGF and ART play a major role in 
regulation of TRPV1 expression and function. With this in mind, we examined trophic support in 
the aged ganglia by measuring the relative expression of TrkA and GFRα3 receptors. Results 
show the relative abundance of GFRα3 is decreased in aged ganglia on both transcriptional and 
translational levels in lumbar DRG while no change was detected in TrkA mRNA, suggesting 
GFRα3-dependent signaling but not TrkA, is selectively affected in aging systems. Though a 
decrease was found in GFRα3, our RT-PCR measures showed an increase in RET receptor 
expression. This increase could reflect an attempt to compensate for the decrease in GFRα3, 
which may occur in response to decreased production of trophic factors or decreased retrograde 
transport due to degenerative changes in peripheral afferents. However, both NGF and ART 
mRNA expression increased in the aging ganglia while no significant loss of target-derived 
neurotrophic factors was detected. Immunocytochemistry showed that the increase in ART 
expression occurred in satellite cells of the ganglia. Whether this increase is related to the 
reduction in GFRa3 is unclear (see below).  
 
 NGF and ART are involved in thermal hyperalgesia induced by inflammation, and NGF 
and ART expression has been reported to increase in inflamed tissue. Surprisingly, in our studies 
CFA injection resulted in a decrease in NGF and an increase in ART mRNA in inflamed skin on 
day 1. This increase in ART was substantially less (2.5-fold vs. 10-fold) compared to other 
studies using young male mice from Jackson labs on the same genetic background, which may 
explain shorter duration of hypersensitivity exhibited by the Harlan mice. We also found that 
increased ART in inflamed skin correlated with a decrease in GFRα3 expression in both ganglia 
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and peripheral nerves, and that as ART increased, GFRα3 level decreased. This suggests that 
increasing the concentration of ART in peripheral tissues can down-regulate GFRα3 expression. 
Although the mechanisms underlying regulation of GFRα3 expression by ART are unknown, 
production of ART in satellite cells of the ganglia may have a role. Results show an increase in 
ART protein in satellite cells of the aging ganglia. Ganglia and nerves of aging mice were found 
to have less GFRα3 protein. This reduction in GFRα3 may therefore result from feedback caused 
by the increase in ART found in supporting satellite cells. 
 
 Sensory ganglia from aging animals were also found to have an up-regulation of genes 
associated with immune/inflammation responses. In DRG and peripheral nerves multiple types 
of cells have immune-like function, including Schwann cells, satellite cells, endothelial cells, 
dendritic cells and macrophages etc., and therefore could be producing these transcripts. Immune 
activation of these cells could potentially release inflammatory cytokines as well as growth 
factors like NGF and thereby induce an inflammatory response (Watkins and Maier, 2002). 
Inflammatory cytokines can interact with growth factors as well as regulate expression of growth 
factors, which is especially true for NGF during inflammation. LIF has been shown to inhibit 
NGF expression in skin and diminish thermal hyperalgesia induced by CFA (Banner et al., 
1998). In our CFA study we found that IL-6 had a linear inhibitory effect on ART expression in 
skin following inflammation, suggesting that ART might also contribute to inflammation, which 
can be regulated by other inflammatory cytokines. It has been reported that CFA-induced up-
regulation of IL-6 in inflamed tissue is dramatically inhibited in LIF knockout mice compare to 
wild-type animals (Zhu et al., 2001). In the comparative study of Harlan and Jackson mice, the 
different fold changes of IL-6 in inflamed skin might be due therefore, to the difference in 
baseline level of LIF in the Harlan and Jackson mouse skin. Similarly, the lower baseline level of 
LIF in skin of aged animals could explain, in part, their reduced sensitivity following CFA 
injection. In conjunction with the findings of increased ART and decreased GFRα3 in aged 
ganglia and following inflammation, we think it possible that ART may act as an inflammatory 
mediator involved in chronic inflammation and as such, contribute to age-induced changes in the 
peripheral nociceptive system.  
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7.3 REGULATION OF NOCICEPTOR FUNCTION BY ART IN AGING 
 
7.3.1 Regulation of TRPV1 expression by ART 
 
Regulation of TRPV1 expression and function by NGF has been well studied using in vivo and in 
vitro model systems. These studies have shown that NGF not only up-regulates TRPV1 
expression but also sensitizes TRPV1 activity via TrkA-mediated signaling pathways in 
nociceptors, and contributes to inflammation-induced thermal hyperalgesia (Ji et al., 2002; 
Bonnington and McNaughton, 2003; Zhang et al., 2005). Our results using calcium imaging are 
consistent with these findings. We found that NGF up-regulates TRPV1 expression as reflected 
by greater CAP responses in young DRG neurons cultured in NGF-containing media compared 
to neurons in media without growth factor (Ji et al., 2002; Zhang et al., 2005). Moreover, in the 
presence of NGF alone in the growth media, no difference in either the percentage of CAP (+) 
neurons or the magnitude of CAP responses between young and old neurons was found, 
consistent with our assays showing TrkA mRNA level in aged ganglia was similar to that in 
young ganglia. Our findings also support the idea that TrkA-mediated neurotrophic signaling is 
not changed in DRG with age, which has been demonstrated in other studies (Jiang and Smith, 
1995; Jiang et al., 1995; Hall et al., 2001). More recent studies have shown that ART also 
regulates TRPV1 expression and function and when injected causes acute thermal 
hypersensitivity. Indeed the regulatory effects of ART on TRPV1 are even greater than NGF 
(Elitt et al., 2006; Malin et al., 2006). However, comparison of young DRG neurons grown 
overnight in ART-containing media with those cultured in media without growth factor showed 
no significant difference in the percent of CAP (+) neurons or the magnitude of CAP responses. 
This suggests that ART alone may not be sufficient to regulate TRPV1 expression in sensory 
neurons. Another possibility however, is that overnight exposure of cultured neurons to high 
levels of ART desensitized TRPV1, reducing the CAP response.  
 
       As mentioned above, previous studies have shown that NGF alone can increase TRPV1 
expression via TrkA signaling and this effect is not affected by aging. Interestingly, we found 
that adding ART into NGF-containing media caused a reduction in the magnitude of CAP 
responses in young DRG neurons but no change in old neurons, indicating that ART may down-
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regulate TRPV1 protein when added with NGF. If so, this effect of ART may depend entirely on 
GFRα3 signaling, which is decreased in aged ganglia. This could explain why old neurons are 
less sensitive to ART treatment. Although the detailed mechanisms of TRPV1 regulation by 
ART are not clear, GFRα3 is the only known receptor to date that can specifically bind to ART 
and is thought to be required for ART effects on TRPV1. This is supported by the finding that 
up-regulation of GFRα3 in DRG of mice with ART overexpression and during inflammation is 
correlated with increased expression of TRPV1 in the PNS and thermal hypersensitivity (Elitt et 
al., 2006; Malin et al., 2006). We also found that aging and inflammation-induced down-
regulation of GFRα3 was correlated with reduced TRPV1 expression in the PNS and impaired 
thermal sensitivity in aged mice, and further confirmed involvement of GFRα3 in regulation of 
TRPV1-dependent nociception. However, in our studies we did not find a positive correlation 
between ART and GFRα3 in the PNS as reported in other studies (Ceyhan et al., 2006; Elitt et 
al., 2006). Thus, how ART regulates GFRα3-dependent signaling remains unclear.  
 
7.3.2 Regulation of TRPV1 function by ART 
 
Although addition of ART decreased the magnitude of CAP responses in young neurons grown 
in media with NGF, the percentage of CAP (+) neurons cultured in NGF and ART-containing 
media was increased from ~30% to ~40% in both young and old animals. Since the amplitude of 
CAP responses was decreased in young neurons, the greater percentage of CAP (+) neurons 
could not be due to increased expression of TRPV1. It is very possible that TRPV1 function or 
activity is upregulated by ART in the presence of NGF. ART alone can potentiate CAP 
responses and reverse TRPV1 desensitization by repetitive application of CAP in vitro, which 
has been confirmed by our own studies. Phosphorylation is one important mechanism underlying 
sensitization of TRPV1 by NGF, ATP and other inflammatory mediators (Tominaga and 
Tominaga, 2005), and maybe also by ART via GFRα3-RET signaling. As discussed earlier, 
phosphorylation is required for activation of TRPV1 by CAP binding, and CAP cannot activate 
less phosphorylated or dephosphorylated TRPV1. ART alone in the media increased the 
percentage of CAP1 (+) neurons that can be activated by the first exposure to CAP, indicating 
that TRPV1 is more easily activated by CAP in the presence of ART in spite of no significant 
effect on TRPV1 expression or function found in young neurons, and this effect may be due to 
 86 
increased phosphorylation by ART. In the presence of ART with NGF in media more TRPV1 
might be phosphorylated and then easily activated by CAP, though the magnitude of CAP 
responses decrease. The overall result may be what we observed; that more neurons respond to 
CAP and among them more neurons are activated by the first CAP application. Since TRPV1 
phosphorylation via ART may also require GFRα3, less GFRα3 found in aged ganglia may 
account for less increase in the percentage of CAP1 (+) neurons dissociated from aged ganglia 
following addition of ART into NGF-containing media. More interestingly, potentiation of 
TRPV1 by ATP was inhibited in young neurons cultured in media containing ART alone, and 
addition of ART into media containing NGF inhibited ATP potentiation in both young and old 
neurons. PKC-dependent phosphorylation of TRPV1 is involved in sensitization of TRPV1 by 
ATP, which can bind and activate GPCRs such as P2Y2 which in turn activate downstream PKC 
(Tominaga et al., 2001). Inhibition of ATP potentiation by ART suggest that ART and ATP may 
share the same downstream PKC-dependent pathways and/or the same phosphorylation sites in 
TRPV1 such as Ser 502 and Ser 800 (Numazaki et al., 2002).   
 
7.3.3 Regulation of VGCC expression by ART 
  
Previous studies have shown age-dependent alterations in VGCCs in both CNS and PNS, which 
can affect neuronal excitability and function (Kostyuk et al., 1993; Murchison and Griffith, 1995; 
Landfield, 1996). We also detected decreased gene expression of Cav2.2 in aged DRG. Since 
one splicing variant of Cav2.2, e37a, has been found preferentially expressed in CAP responsive 
DRG neurons, 67% of which also express GFRα3, it is possible that overexpression of ART may 
cause up-regulation of Cav2.2-e37a expression in sensory ganglia. Unexpectedly a 1.6-fold 
decrease of Cav2.2-e37a mRNAs was measured in lumbar DRG of ART-overexpressing mice 
(data not shown). Consistent with this finding, addition of ART into NGF-containing media 
decreased the amplitude of KCl-induced and VGCC-dependent Ca2+ transients in young CAP 
responsive neurons but not in old neurons which have less GFRα3 on the average, indicating that 
regulation of Cav2.2-e37a by ART can occur through GFRα3 signaling. Systemic treatment with 
ART has been found to relieve experimental neuropathic pain in rats by decreasing CAP-induced 
neurotransmitter release in the dorsal horn of the spinal cord (Gardell et al., 2003). A more recent 
study also found that ART could attenuate herpes-related pain responses in mice infected with 
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herpes simplex (Asano et al., 2006). Our results suggest that the analgesic effect of ART might 
rely on down-regulation of TRPV1 and Cav2.2 expression, and that this effect is absent in old 
neurons and therefore age-dependent. In contrast, the inhibitory effect of ART on TRPV1 
potentiation by ATP is not affected by age. It should be noted that we used Ca2+ imaging to study 
TRPV1 expression and function in vitro by analyzing CAP induced TRPV1-dependent Ca2+ 
transients, which can reflect molecular and physiological properties of TRPV1 to some degree. It 
is not clear how well CAP induced Ca2+ transients correlate with TRPV1 expression and activity. 
However, most studies indicate that upregulation of TRPV1 increases CAP responses 
(Bonnington and McNaughton, 2003; Elitt et al., 2006; Malin et al., 2006).   
 
7.3.4 Specificity of ART effect on nociceptors in aging  
 
In mouse DRG the majority of TRPV1-positive neurons are NGF- responsive nociceptors, ~67% 
of which express GFRα3. Nearly all GFRα3-positive sensory neurons express TRPV1, 
suggesting that ART may differentially regulate NGF-dependent but not GDNF-dependent 
nociceptors in mice. This specificity has been supported by development studies. During 
development ART selectively supports a subpopulation of nociceptors expressing GFRα3 and 
the majority of them are NGF-responsive nociceptors. Our findings suggest that ART may also 
be specifically involved in aging of NGF-dependent nociceptors by regulation of GFRα3 
signaling in mouse. ART and NGF are two major factors that regulate TRPV1-expressing NGF- 
responsive nociceptors whereas GDNF has less effect on TRPV1-mediated nociception. During 
aging GDNF-GFRα1 neurotrophic signaling does not change in DRG, therefore GDNF-
dependent nociceptors should be less affected by age. Indeed, no age-related changes in gene 
expression or protein level of P2X3, a Ca2+-permeable channel that can be activated by ATP and 
also predominantly expressed in GDNF-dependent nociceptors, were found in sensory ganglia, 
peripheral nerves and hind paw skin (data not shown). In vitro Ca2+ imaging studies, though 
lacking in specificity, also consistently showed that ATP induced Ca2+ transients in sensory 
neurons did not change with aging (data not shown). In contrast, GFRα3 signaling is decreased 
in aged DRG, which is correlated with increased ART and decreased TRPV1 expression and 
function despite no change in TrkA signaling in aged DRG. These findings indicate a specific 
effect of ART on TRPV1-expressing NGF-responsive nociceptors in mice during aging.  
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7.4 SUMMARY AND CONCLUSIONS 
 
To understand the molecular mechanisms in aging of the peripheral nociceptive system, we 
compared gene expression associated with nociception, neurotrophic signaling, and immune 
/inflammation in the cutaneous sensory system between young and old mice under normal 
conditions and following inflammation. We found that gene expression of channels and receptors 
involved in nociception, such as Nav1.8, Nav1.9, Cav2.2 and ETRB, decreased in aged DRG. 
The levels of TRPV1 and Nav1.8 protein were also reduced in DRG or peripheral nerves with 
aging. Following inflammation TRPV1 protein was decreased in peripheral nerves in both young 
and old mice and this reduction correlated with reduced thermal hyperalgesia. These findings 
support a mechanism whereby these molecular changes contribute to impaired thermal sensation 
during aging. To determine whether altered neurotrophic signaling is involved in age-modulated 
expression of these channels and receptors, particularly TRPV1 in this study, we measured 
NGF/TrkA, GDNF/GFRα1 and ART/GFRα3 transcripts in DRG and found a reduction in 
GFRα3 and no change in TrkA or GFRα1, though the ligands NGF and ART increased in aged 
DRG. Inflammation further increased ART expression in inflamed skin and decreased GFRα3 
expression in DRG or peripheral nerves in both young and old mice. Increased ART expression 
during inflammation is linearly correlated with expression of the inflammatory cytokine IL-6 in 
inflamed skin, suggesting that ART might also act as an inflammatory factor and interact with 
other inflammatory cytokines. The decrease in GFRα3 may result from an inflammation-induced 
increase in ART.  
 
Aged animals exhibited an increase in genes associated with immune/inflammation, such as IL-
6, and decreased expression of genes associated with glial support function, like ETRB and 
myelin, in the DRG. These findings suggest that age compromises the normal support function of 
glial cells and activates immune cells and/or immune-like glial cells in sensory ganglia. These 
activated immune or immune-like cells may contribute to increased expression of inflammatory 
genes and growth factors including ART and NGF in aged ganglia. Increased production of ART 
may selectively decrease GFRα3 signaling in nociceptors, and in turn down-regulate TRPV1 
expression and function and reduce thermal sensitivity during aging (Figure 7.1). Consistent 
with the in vivo findings, in vitro studies of isolated DRG neurons using calcium imaging
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Figure 7.1 Paradoxical effects of ART on thermal nociception. During development and following acute 
inflammation, an increase in ART expression in glial, target and/or immune cells has a hyperalgesic effect 
on thermal sensation perhaps via up-regulation of GFRα3 and TRPV1 activity in NGF-dependent 
nociceptors. During aging and chronic inflammation, supporting function of glial, target and/or immune 
cells may be decreased while immune function is increased, and an increase in ART expression in these 
cells has an analgesic effect on thermal sensation probably via down-regulation of GFRα3 and TRPV1 
activity in those nociceptors.  
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indicate that long-term exposure to ART decreases the amplitude of CAP-induced TRPV1-
dependent Ca2+ transients. This effect is absent in aged neurons that have less GFRα3 found in 
vivo, suggesting that TRPV1 down-regulation by ART depends on GFRα3 signaling.  
 
       Together with other studies of ART in development and acute inflammation, two different 
and paradoxical effects of ART on thermal nociception have been found (Figure 7.1). During 
development and acute inflammation, an increase in ART expression has a hyperalgesic effect on 
nociceptors by upregulation of TRPV1 through GFRα3-RET signaling and induction of thermal 
hypersensitivity. During aging and chronic inflammation, increased ART expression has an 
analgesic effect on nociceptors by down-regulation of TRPV1 through the same GFRα3-RET 
signaling and reduce thermal sensitivity. In fact, the analgesic effect has already been shown by 
previous studies that ART treatment can relieve experimental pathological pain. Our studies also 
suggest that inflammation may be a major mechanism in aging of the peripheral nociceptive 
system, and an increase in ART expression and inflammatory related molecules by glial and 
immune-like cells in sensory ganglia may be a key factor in aging of NGF-dependent nociceptors 
in mice. Certainly, more evidence, such as aging of ART knockout mice, is required to support 
this theory. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 91 
Table 7.1 List of abbreviations 
 
Abbreviation  Full name      Note  
AP   Action potential 
AHP   Afterhyperpolarization 
ART   Artemin      Neurotrophic factor  
ASIC   Acid-sensing ion channel 
BDNF   Brain-derived neurotrophic factor  
CAP   Capsaicin      TRPV1 agonist  
Cav2.2   Voltage-gated calcium channel 2.2 
CFA   Complete Freund’s adjuvant    Inflammatory reagent 
CGRP   Calcitonin gene-related peptide   Neurotransmitter 
CNS   Central nervous system  
DRG   Dorsal root ganglia 
ETRB   Endothelin receptor type B 
ER   Endoplasmic reticulum 
GDNF   Glial cell line-derived neurotrophic factor  
GFRα   GDNF family receptor alpha 
IL-6   Interleukin-6                Inflammatory cytokine 
LIF   Leukemia inhibitory factor              Inflammatory cytokine 
Nav1.8  Voltage-gated sodium channel 1.8 
NGF   Nerve growth factor     Neurotrophic factor 
NTN   Neurturin      Neurotrophic factor 
PNS   Peripheral nervous/nociceptive system 
TG   Trigeminal ganglia  
TRPV   Transient receptor potential vanilloid receptor 
VGCC   Voltage-gated calcium channel 
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